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Aim	of	this	thesis
The aim of this thesis is to gain insight in the function of the FXR proteins, with special emphasis 
on their role during embryonic development. The FXR gene family is a small family of genes, 
including FMR1, FXR1 and FXR2, of which FMR1 is involved in the fragile X syndrome. The 
cellular function of the FXR proteins has been studied most thoroughly for FMRP using a knockout 
mouse model. Although no disease has been identified thus far involving FXR1P or FXR2P, the 
function is thought to be similar to FMRP, due to its high homology of important functional 
domains and similar expression patterns in the brain. The generation and characterisation of 
Fmr1 and Fxr1 KO mice suggest an important role of both FMRP and FXR1P during embryonic 
and postnatal development. However, the early embryogenesis is difficult to study in detail 
in mouse embryos due to their intrauterine development. This problem can be overcome by 
studying FXR gene function in zebrafish embryos.
The introduction (chapter 1) consists of 2 parts; the zebrafish (part 1) and the FXR protein 
family (part 2). Part 1 gives a general overview of the zebrafish as an animal model and the 
applications in zebrafish research. Some aspects will be described in more detail due to its 
relevance for research involved in this thesis, like chapter 1.5 Gene knockdown technologies. 
The second part of the introduction describes the FXR protein family. For more detailed 
descriptions regarding the fragile X phenotype, FXR mouse models and the function of FMRP 
in the brain, I refer to the publication of the corresponding thesis from our department 1-3. In 
chapter 2, the Fxr proteins are identified in Xenopus tropicalis, another model organism suitable 
to study embryonic development. Chapter 3 and 4 describe the characterisation of Fmrp and 
Fxr1p in zebrafish. In chapter 5, the function of Fxr1p is studied using the antisense morpholino 
knockdown technique and the fxr1 morphants are further characterised. The use of zebrafish as 
a model for human disease, the fxr1 morphants and the possible cellular function of Fxr1p are 
discussed in chapter 6.
Chapter	1
Introduction
Chapter	1
Introduction
1	The	zebrafish
1.1 The zebrafish as an animal model for human disease
The Latin name for zebrafish is Danio (formerly Brachydanio) rerio, which originates from 
the river Ganges in India and is common as an aquarium fish throughout the world 4. Zebrafish 
belong to the cyprinid family of teleost fish (figure 1). In 1981, George Streisinger introduced 
the fresh water tropical zebrafish as a genetic model to study vertebrate development.  Due to 
its transparent embryo that develops outside the mother’s body the zebrafish represents an ideal 
vertebrate model system to study embryonic development. All developmental stages, including 
organogenesis, are clearly visible within the embryo and are described in detail by Kimmel et 
al and Haffter et al 5,6. 
Figure	 1. Phylogenetic trees of vertebrates and fish. A) Evolutionary tree of the chordates and vertebrates. B) 
Evolutionary tree of the bony fish (Osteichthyes). Zebrafish belongs to the euteleosti and ostariophysi.  (Figure 
adapted from Campbell et al 1999).
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Zebrafish is a relatively simple vertebrate and there is considerable conservation of pathways 
across species. This means that, despite teleost fish diverged more than 400 million years 
ago, they are more closely related to humans than invertebrates and thereby offer numerous 
advantages to researchers interested in many aspects of embryonic development, physiology 
and disease. By virtue of their being more closely related to humans, they have many biological 
functions comparable to human and hence many cellular processes have been conserved. 
Furthermore, it is becoming more and more clear that all vertebrates follow an evolutionary 
conserved developmental program.
The small size of the zebrafish (3-5 cm), their ability to be kept in large numbers, and the ease of 
breeding make them easy to maintain. Breeding and collecting eggs from the zebrafish is relatively 
easy. Since, zebrafish are photoperiodic in their breeding they are kept at a day-night cycle with 
an automatic timer (14 hrs light/10 hrs dark). The day before fertilisation, male and female fish 
are maintained separate using a special breeding tank with two separate compartments divided 
by a removable partition. By simply removing the partition in the morning, shortly after sunrise, 
embryos will be produced. As mentioned above, the fertilisation of eggs occurs externally and 
females are very fecund generating hundreds of eggs on a weekly basis.
The embryos develop quickly from a single cell to something that is recognizable as a fish 
after 24 hours of development. Between four and eight hours post fertilisation (hpf) several 
characteristic processes occur, including epiboly, involution and convergent extension. 
These processes start with the migration of the cells (approximately 1200 cells) over the yolk 
followed by extensive rearrangements. Subsequently, in the next three hours the three primary 
embryonic germ layers are formed through cell movements, a process called gastrulation. After 
gastrulation is complete, at around eleven hpf, the basic vertebrate body plan has developed 
and the formation of the first individual somites will begin. Somitogenesis starts anterior (close 
to the head) and sequentially moves towards the tail of the embryo (posterior). At 18 hpf, 18 
somite pairs are formed and the total number that eventually forms is variable, from 30 to 34 
pairs. At 24 hpf, a heartbeat and associated blood flow can be recognized. Within 48 hours after 
fertilisation all common vertebrate specific body features can be seen. Larvae hatch and are able 
to swim and search for food within 5 days. The generation time of the zebrafish is 2-3 months. 
For a schematic presentation see figure 2. The external fertilisation and the development outside 
the mother make it easy to access the embryos and to manipulate them, including exposure of 
larvae/fish to water-soluble chemicals and drugs. The transparency of the embryo enables us 
to follow the development in vivo. The accessibility and transparency in combination with a 
fluorescent marker make it possible to visualise detailed developmental cellular movements 
using real time imaging. In contrast, the embryonic development of a mouse takes 21 days. To 
study mouse embryos, the mother has to be sacrificed to get at the embryos, which sacrifices 
them as well. Due to these features the zebrafish has become an important model organism to 
determine the in vivo function of a gene (functional genomics) during embryonic development. 
Two general approaches are used to reveal the function of a gene: forward and reverse genetics. 
The process of forward genetics starts with a mutant phenotype and moves towards the gene; this 
was the first approach in functional genomics. The attractive features of zebrafish, as mentioned 
above, led to large-scale mutagenesis screenings in zebrafish 6-8. It is easy to chemically induce 
mutations in the germ cells in the testis of adult zebrafish, which may give a phenotype in their 
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offspring. This procedure will be described in more detail in chapter 1.3. The process of reverse 
genetics starts with a particular gene and assays the effect of its disruption, that is, studying the 
phenotype associated with the mutant gene. This approach usually focuses on the inactivation 
of a gene and requires a way to selectively mutate a chosen gene. In general, the inactivation 
of the chosen gene is accomplished by homologous gene targeting, resulting in a complete (or 
sometimes conditional) knockout of the gene. Tools for reverse genetics typically include: gene 
knockouts/knock-ins using homologous recombination in embryonic stem cells (ES), gene 
knockdown using morpholino antisense technology (MO) or RNAi, and targeted induced local 
lesions in genomes (TILLING) technology. Some of these applications in zebrafish research 
will be discussed below in more detail (chapters 1.3, 1.4 and 1.5).
Figure	2.	A schematic representation of the embryonic developmental stages of zebrafish. The cycle starts at the 
top with a fertilized single stage. The embryos develop quickly to a 14-somite stage within 16 hours. After 24 hours, 
the complete body plan of the embryo has been established meaning that all organs are present. Two days after 
fertilisation, the embryos hatch and become free swimming. Zebrafish are adult at 3 months of age and fertile.
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Zebrafish models generated by both forward and reverse genetics are not only used as a genetic 
or developmental model system. The last decade, zebrafish has been successfully applied as 
an organism to elucidate the etiology of human disease. Zebrafish models of human disease 
are widely used in many different fields of medical research, like cancer, infectious diseases, 
cardiovascular disease, kidney disease, diabetes, blindness, deafness, digestive diseases, 
haematopoiesis, muscle disorders and neural disorders (9 and references herein). For instance, 
features that make the zebrafish a good model for human disease are the haematopoiesis 
system and the heart. The haematopoietic process is conserved throughout vertebrate evolution 
and many homologues of blood specific genes have been identified in zebrafish. Like in all 
other vertebrates, haematopoiesis occurs in two phases namely a primitive and a definitive 
hematopoiesis. The use of mutagenesis screens has revealed mutants with defects in ventral 
versus dorsal cell fate patterning, which show either a lack or an expansion of haematopoietic 
cells. For instance, mutagenized zebrafish embryos for red blood cell deficiency resulted in the 
isolation of 26 different mutants 10. The formation of the zebrafish embryonic heart resembles 
the first three weeks of gestation of the human heart and includes segregation of cardiogenic 
precursors (12 hpf), heart tube assembly (24 hpf), chamber formation (30 hpf), heart looping 
(36 hpf), valve formation (48 hpf) and cardiac function (30 hpf) 11. Fortunately, embryonic heart 
function can easily be observed due to the transparency of the embryos. Another advantage 
of zebrafish is their ability to survive early development without blood circulation (reviewed 
in 12). To date, many zebrafish mutants with cardiac defects affecting various aspects of heart 
development have been recognized. Further characterisation of these mutants has led to the 
identification of several key regulators in cardiac development. Importantly, the identified 
(disease) genes have shown to play a conserved role in human cardiac disease as well 13. 
In summary, the zebrafish has become a well-established model organism, making important 
contributions to the identification and characterisation of genes and pathways involved in 
development, organ function and behaviour. Additionally it has become a valuable resource for 
identifying genes involved in human disease.
1.2 The zebrafish genome
The zebrafish is a vertebrate with a diploid genome consisting of 25 chromosomes (1n). Although 
the exact number of genes in zebrafish is currently unknown, estimates about the number of 
base pairs point to approximately 1.7 X 109 base pairs for the haploid genome 14. The zebrafish is 
expected to have at least the same number of genes as the human. Almost all human genes can 
also be found in the zebrafish and approximately 20% of the human genes have two orthologs 
in zebrafish. This suggests genome duplication shortly before the teleost radiation, which was 
either partial or was followed by rapid gene loss. Importantly, if two orthologs are present they 
often show different expression patterns (both spatial and temporal). This suggests that the 
function of the ancestral gene has been divided up between two orthologs with more restricted 
(less complex) functions 15,16.
Sex determination in mammals is usually by the absence or presence of the Y chromosome. 
In fish, different mechanisms of sex determination have been found, however, the precise 
mechanisms are largely unknown. Some fishes have a homo/heterogametic system with 2 
chromosomes, like the mammalian XX/XY system, while other fishes have 3 sex chromosomes. 
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Sex is usually determined genetically but can also be influenced by environmental factors such as 
temperature and pH. Other features seen in fishes are hermaphroditism and sex reversal, which 
can be accomplished by hormone treatment. The mechanism of sex determination in zebrafish is 
unknown. In zebrafish no sex chromosome or sex-linked genes have been identified. However, 
a number of genes have been linked to the process of sex determination and/or differentiation 
in zebrafish. These are autosomal genes of which allelic variants and dosage effects probably 
determine the sex (reviewed in Von Hofsten et al 17). 
In February 2001 the Sanger Institute started sequencing the genome of the zebrafish 
(www.sanger.ac.uk/Projects/D_rerio/). This whole genome-sequencing projects lead to the 
identification of genes of which the in vivo function is unknown. The assembled genomic 
zebrafish sequences are publicly available (http://www.ensembl.org/Danio_rerio/; http://vega.
sanger.ac.uk/Danio_rerio/). In the last Ensembl release of June 2006 more than 21,000 genes 
were identified. Furthermore, the full sequence and assembly of the zebrafish genome facilitates 
evolutionary comparisons of the zebrafish genome with the mouse and human genomes. 
1.3 Mutagenesis screens
The zebrafish is very well suitable for large-scale forward genetic screens in which phenotypic 
defects are identified before the identification of the gene causing these defects. This is due to 
its large quantity of eggs, short generation time and the external development of the transparent 
embryos. In addition, an important practical advantage is that zebrafish sperm can be frozen 
for future studies. The three techniques to induce mutations in zebrafish include chemical 
mutagenesis, gamma irradiation and insertional mutagenesis (reviewed in 9). 
Chemical mutagenesis is the most favourable and efficient method applied thus far 6,7. The 
chemical mutagenesis by exposing adult zebrafish to N-ethyl-N-nitrosourea (ENU) is used for 
these screens. ENU, an alkylating agent, generates point mutations throughout the entire genome 
in premeiotic germ cells by transferring its ethyl group to individual bases of the DNA, which 
are misread by DNA polymerase in subsequent replications. However, most induced mutations 
are recessive and must be rendered to homozygosity to reveal a phenotype. This is accomplished 
by a multi-generation backcross model 6. Mutagenized adult male zebrafish are crossed with 
wildtype females. The F1 offspring are heterozygous for individual mutations and are once 
more crossed with wildtype females. The resulting F2 generation is intercrossed randomly to 
produce F3 families in which homozygous mutations occur. In the F1 and F2 generation, rare 
dominant mutations might occur, but most ENU induced mutations are recessive. Finally, the 
F3 embryos are further selected on defects in organogenesis using microscopic examination 
between 1-5 days post fertilisation (dpf). Positional cloning can then identify the affected gene 
in isolated mutants. Large numbers of mutations that disrupt embryonic development have 
now been isolated in the zebrafish, many of which may serve as models for human diseases or 
syndromes. Further characterisation of these mutants (~2000) and identification of the genetic 
defect will advance our knowledge of the pathogenesis of the corresponding human disease. It 
will advance our understanding of the underlying molecular basis of the disease and ultimately 
may lead to the development of drugs aimed at treatment of the disease.
The second approach to induce mutations disrupting developmental processes in zebrafish is 
radiation, mainly gamma. Gamma-ray mutagenesis produces a very high locus mutation rate of 
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approximately 1:100 and has mainly been used in screens for morphological defects 5. In contrast 
to chemical mutagenesis gamma rays induce translocations and large deletions at high frequency 
in the zebrafish genome and thus chemical mutagenesis is the method of first choice 18. 
The third alternative approach to induce mutations in zebrafish is insertional mutagenesis, 
which can be established by injection of plasmid DNA, a mouse pseudotyped retrovirus or 
using a P-element transposon as insertional mutagens 8. For retroviruses, a molecular tag at 
the site of the mutagenic lesion enables detection of the mutated gene. Although the efficiency 
of the mutagenesis is less than with ENU mutagenesis, the detection is 7 to 8 times higher 
than for ENU induced mutations 19,20. These genetic screens allow the identification of novel 
genes and mutants for specific organs or processes. After examining the phenotypes by random 
mutagenesis, the mutation responsible for the specific defect has to be found using positional 
cloning. Major drawback of forward genetics is that it is slow and laborious due to positional 
cloning methods.
Mutagenic screening technology using a reverse genetic approach has been established as 
well. In 2002, due to the lack of a working protocol to produce an ES-cell-based knockout (or 
targeted gene expression) the TILLING technique was developed 21-23. TILLING (Targeting 
Induced Local Lesions IN Genomes) involves random induced mutations by ENU and 
subsequent screening for mutations in target genes. This screen is an enzyme-mediated (CEL-
I endonuclease) mismatch recognition procedure to detect heterozygous germ line mutations 
in the F1 generation. Further generation of embryos with mutant phenotypes is similar to the 
breeding scheme described above. TILLING can be performed in a high-throughput setup. 
The only disadvantage is that the mutations are randomly introduced. The TILLING method 
would lead to more null mutants in zebrafish than achieved by homologous recombination in 
mice 24,25. Initially, TILLING was developed to reduce the time and costs of mutation detection 
using DNA sequencing 25. However, recent advances in DNA sequencing technology make 
this method equal to TILLING 26. Thus far several null mutants have been generated using 
the TILLING technology and recently a homozygous fmr1 null mutant has been identified (E. 
Cuppen, Hubrecht Lab; personal communication). To exploit the advantages of the zebrafish 
to produce disease models a consortium of European zebrafish groups have been funded and 
includes the generation of targeted knockout zebrafish on request (see www.zf-models.org).
1.4 Transgenic and knockout zebrafish
Genetically modified animal models are widely used to characterize the function of many newly 
identified (disease) genes. Transgenic techniques in the mouse to generate transgenic and loss-
of-function mutations are well established and have improved our understanding of the roles of 
specific gene products significantly. Genetically modified mice also serve as valuable models 
to study the pathogenesis of human disease and to test or develop experimental treatment 
regimes. However, with the zebrafish emerging as an important model organism to study human 
disease, the development of similar or additional genetic techniques specifically focused on 
zebrafish was needed. Methods for generating a transgenic zebrafish are pseudotyped retrovirus 
infection 19,27,28, transposons 29-31, transfection of sperm nuclei 32 and DNA microinjection. The 
latter is the most frequently used method for generating transgenic lines expressing a gene of 
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interest. DNA microinjection can be achieved by injection of plasmid DNA or bacterial artificial 
clones (BACs) into the cytoplasm of a 1-cell stage embryo. The frequency of DNA integration 
into the germline by microinjection in zebrafish is 1-30%, which is comparable to mouse 33. 
Coinjection of I-SceI meganuclease and a construct flanked by meganuclease recognition 
sites has been shown to improve the integration in fish 34. The gene of interest is randomly 
integrated or under the control of a general or tissue-specific promoter. An example of a gene 
of interest could be GFP under the control of a tissue-specific promoter and thereby generating 
a cell-specific fluorescent transgenic fish line. A number of fluorescent transgenic fish lines 
are commercially available (e.g. GFP-red blood cells or GFP-neurons). Fluorescent imaging 
using for instance confocal microscopy makes it possible to investigate detailed developmental 
processes like gene expression, single cell migration etc.
Another approach to investigate the function of a (disease) gene in an animal model is to 
inactivate or disrupt the gene of interest. A major advance in the ability to generate mouse 
disease models was the development of technology that makes it possible to introduce loss-of-
function mutation into endogenous genes and then transmit these through the mouse germ line 
(reviewed in 35). The desired null mutations are first created via homologous recombination in 
embryonic stem (ES) cells, which contribute to all cell lineages when injected into blastocysts. 
However, mouse developmental genetics is impeded by the high cost of maintenance of animals 
and by the intrauterine mode of development. Because of the expense and effort required to 
produce a genetically modified mouse and the inaccessibility of the embryos inside the mother, 
the zebrafish might be the vertebrate model to allow these genetic techniques. 
The strategy to generate knockout zebrafish by the germ line transmission of targeted loss-
of-function alleles using ES cells, as described for mice, has not yet been achieved. The only 
method to produce a knockout zebrafish was mutagenesis followed by targeted screening for 
point mutations as described above 21. Pluripotent zebrafish ES cell lines have been established 36. 
Recently, targeted incorporation of plasmid DNA into these cells by homologous recombination 
followed by in vitro drug selection was successful 37. In addition, the authors were able to 
introduce these ES cells, expressing a marker gene such as GFP, into host embryos using 
microinjection techniques and achieved contribution to the germ line. Although the frequency 
of germline chimera production was 2-4%, the availability of large quantities of fertilized eggs 
makes it potential feasible to establish a knockout fish line in the near future 37. Alternatively, 
Wu et al. described a novel method to generate site-directed knockout or knockin zebrafish 
without the use of embryonic stem (ES) cells. By microinjection of targeting plasmids, the 
endogenous growth hormone (GH) receptor was disrupted either by knockin of a ß–promoter 
or by knockout of the GH receptor. Correct integration of target genes was identified by dual 
selection using GFP and RFP for a positive and negative selection, respectively. They found 2-
3% of potential founder knockout had the characteristic of germ line transmission 38.  
In summary, these results show the potential for generating a knockout/knockin zebrafish 
targeted gene modification through homologous recombination, either with or without the 
culture of embryonic stem cells. 
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1.5 Gene knockdown technologies
Zebrafish reverse genetics is slowly catching up with Drosophila and/or mouse, as the techniques 
to perform gene-specific knockdowns, target-selected mutagenesis and transgenesis in zebrafish 
are quickly developing. Next to the ability to make a knockout (see above), the generation of a 
morpholino-mediated knockdown zebrafish was the favourite technology thus far to study gene 
function in zebrafish (reviewed by 39). Currently the use of antisense modified oligonucleotides 
is still widely applicable due to their ease and quick results. Although morpholinos have been 
tested in different species, including sea urchin, ascidian, frog, chicken and mouse the most 
favourable model organism to test morpholinos has been carried out on zebrafish embryos. 
Morpholinos (MOs) are synthetic oligonucleotides of 25 bases, which hybridise specifically to 
complementary sequences of mRNA, disrupting translation initiation or pre-mRNA splicing. 
The backbone of MOs is similar to the backbone of DNA or RNA, but with some changes. In 
MOs, the ribose or deoxyribose sugar molecules that link the bases of the DNA or RNA are 
replaced by morpholino rings (hence the name). Anionic phosphates of bases replace non-ionic 
phosphorodiamidate linkages. Due to this modified backbone, the MO is uncharged, very stable 
and cannot be degraded by nucleases. (More details about MOs see www.gene-tools.com). The 
reduction of translation will never be 100%, but can be up to 90%, and is therefore called a 
knockdown (figure 3). Zebrafish embryos displaying a phenotype as a consequence from ectopic 
MO administration are called morphants 40.
Figure	3. Differences between the gene knockout technologies, often used in mice, versus the gene knockdown 
technology in zebrafish. In case of knockout, the gene becomes fully inactivated at the level of transcription and 
subsequent total lack of protein. Knockdown by morpholinos occurs either on the level of RNA processing or 
translation. The injected morpholino technology can be designed against either a splice site or start site of the target 
mRNA. When a morpholino is targeted against a splice site, an exon could be spliced out or an intron could be 
spliced in during pre-mRNA processing. This incorrect splicing of the mRNA leads to aberrant or truncated protein. 
If the morpholino is targeted against the start site the translation initiation complex is blocked and results in reduced 
protein expression (up to 90%). Another important difference between knockout and knockdown is the effect, which 
is 100% for knockout and maximum 90% for knockdown.
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The MOs can either be microinjected in the cytoplasm of a 1-cell stage embryo or into the 
yolk of a 1- to 16-cells stage embryo. MOs can diffuse into the cell until a 16 cells stage when 
a membrane is formed between the yolk and the cells that will form the actual embryo. MOs 
can be dissolved in Danieau buffer, which is thought to reduce lethality. As an injection tracer 
0,05% Phenol Red can be added, which also works as a pH indicator and will turn yellow if the 
MO solution is acidic. MOs will directly bind to endogenous (also maternal) mRNAs at either 
the translational start site and disrupt translation initiation. However, MOs can also be designed 
against a splice junction, thereby preventing correct splicing into a mature mRNA 22,41. This 
aberrant splicing includes exon deletion or intron insertion, which might lead to premature 
stop or a non-functional protein. Knockdown of gene function is transient and effective until 
3 to 5 days of development due to dilution of the MOs. MOs exert their effect throughout 
embryogenesis in a dose-dependent fashion, thereby allowing the identification of morphants 
that might be masked or lethal in case of null mutations 40. Interestingly, MOs against different 
genes of interest can be co-injected simultaneously to either study/exclude redundant function 
or assess interactions between gene products within a pathway. Large quantities of eggs can be 
microinjected in one experiment and due to the fast development of the embryos, a phenotype 
can often already be observed after 24 hours. MO microinjection might cause non-specific side 
effects thus control experiments are necessary. These controls could be microinjection of a 
second and/or mismatch MO or coinjection of target mRNA and MO to rescue the phenotype. 
The efficacy of depletion of the target protein is crucial and should be analysed by Western 
blotting using monospecific antibodies against the target protein. However, this can only be 
applied for MOs that disrupt translation. For MOs that result in aberrant spliced mRNA, all 
outcomes can be characterised and quantitated by RT-PCR 41. 
Another approach for targeted knockdown is using RNA interference (RNAi). RNAi is 
the process of sequence-specific posttranscriptional gene silencing (PTGS), initiated by 
the introduction of double-stranded (ds) RNA. In invertebrates such as C. elegans and D. 
melanogaster, microinjection of dsRNA leads to specific silencing of genes highly homologous 
to these dsRNA, which activates a cascade leading to degradation of the mRNA (reviewed in 
42,43. However, in zebrafish the RNAi-mediated knockdown appeared only moderately efficient 
and moreover showed non-specific effects using dsRNAs 44-47. To overcome these non-specific 
effects, mammalian specific gene silencing approaches have been developed for zebrafish using 
short interfering RNAs (siRNAs) and retroviral short hairpin RNA (shRNA) 48. Recently, the 
approach of siRNAs-mediated gene silencing has been applied successfully for the zebrafish 
dystrophin gene 49. This study demonstrates the effective use of gene silencing via siRNA in 
zebrafish, albeit in a brief temporal manner. Future research should be focused on the generation 
of stable lines of transgenic zebrafish expressing either siRNAs or shRNAs to overcome the 
transient siRNA. 
1.6 Behavioural tests
The rapidly increasing number of zebrafish mutants from the mutagenesis screens and 
knockdown/transgenic strategies will result in zebrafish with defects in overall embryonic 
pattern, morphogenesis or organ formation. Initial phenotypic characterisation is done by 
microscopically screening all morphological features of embryos of 1-5 dpf. A screen of defects 
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in organogenesis is described by Haffter et al 6. Next step is to characterize the phenotype 
by methods using molecular probes like in situ hybridisation and/or (immuno) histochemical 
techniques or biochemical tests. Other important aspects of characterisation of the phenotype 
are behavioural studies. For mice these tests are well defined, however, with respect to zebrafish 
behaviour surprisingly little is known. 
Zebrafish is a typical diurnal schooling fish that prefers light to dark during the day. However, 
in response to danger they hide in the dark. Males exhibit territoriality, including dancing 
movements and agonistic behaviour. Zebrafish embryos (0-5 dpf) already exhibit simple sensory 
and locomotor abilities, whereas larvae (5-14dpf) possess many patterns of behaviour. Some 
simple behavioural tests concerning locomotion of the embryos/larvae have been described, 
like rhythmic tail movements, the escape response, equilibrium control and the touching assay. 
More sophisticated assays to identify defects in optokinetic and phototactic behaviours have 
been described as well 50-52. Recently, a system to monitor behaviour in zebrafish has been 
established. Ethovision from Noldus is a computerized video tracking system that enables to 
record movement of animals including swimming patterns of small sized fish. The fish can 
be monitored in an open tank as well as a 96-well plate for high throughput screens. The 
coordinates of the swimming performance can be stored and used for further software analysis. 
Many behavioural tests can be performed due to automated locomotion recording and data 
analysis 53.
Learning and memory have been studied in many model organisms. Each species uses its own 
specific behavioural paradigms. Also for zebrafish a simple spatial alternation paradigm for 
evaluation of spatial learning and memory function has been developed 54. This paradigm is 
based on an aquatic version of an alternation task (T maze) commonly used for rats and mice. 
The fish received a food reward after choosing the correct arm when they observed a light tap 
on the tank. A similar approach has been applied for the use of different colours to show visual 
discrimination learning 55. Very recently, the aquatic T-maze has been combined with an automated 
tracking and analysis system (Ethovision) to track zebrafish reliably at a high sample rate.
These newly developed behavioural assays for zebrafish will help to characterize (new) zebrafish 
mutants produced by large-scale forward genetic screens and reverse genetics approaches.
1.7 Myogenesis in zebrafish
Myogenesis is a complex process that is conserved among vertebrate striated muscles. The 
formation of muscles within the vertebrate embryo starts during somitogenesis. Somites originate 
from the paraxial mesoderm. The dorsal part of an amniotic somite gives rise to a transient 
epithelial structure called the dermomyotome, which gives rise to the dermis and another 
compartment, the myotome. However, in non-amniots, like the zebrafish, no dermomyotomal 
stage could be identified for myotome formation. In zebrafish, initiation of muscle development 
occurs before the onset of somitogenesis within the adaxial cells 56. These cells start the 
myogenic differentiation by expressing myogenic regulatory factors, such as myf5, myoD and 
myogenin, and myosin heavy chain genes 57-59.  The adaxial cells lie adjacent to the notochord, 
migrate laterally of the somite and elongate into mononucleated slow muscle fibres 56. A subset 
of adaxial cells does not migrate and remain next to the notochord. These specific adaxial cells 
are called muscle pioneer cells and differentiate into the horizontal septum, which forms a 
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separation between the dorsal and ventral domains of the developing myotome 56,60. With this 
adaxial cell migration, the rest of the cells follow to form the myotome. The slow muscle fibres 
act as a template for the differentiation of fast muscle fibres, which develop from the remainder 
of the presomitic cells 56,60-63. The mechanism of myotomal growth resembles the amniotic 
program. First, the number of slow muscle fibres increases from a monolayer to a thicker layer 
and starts to grow towards the dorsal and ventral side of the myotome 64. The next step is fusion 
of muscle fibres, which are mononucleated myoblasts and become multinucleated myotubes. 
The process of myofibre formation is called myofibrillogenesis.
The elongation of the muscle fibres is inhibited by boundaries. These boundaries are formed due 
to somite formation, which occurs as the myotome is formed. First, an initial epithelial somite 
boundary is formed, which changes into a transitional boundary. During this second stage of 
boundary formation, muscle fibres migrate laterally (as described above) and focal adhesion 
molecule appears at the boundary. In this stage the chevron-shaped somite becomes visible. 
The final stage is the formation of the myotome boundary, which is rich of extracellular, focal 
adhesion and dystrogyclan components 65-67. 
During myofibrillogenesis, assembly of structural proteins is necessary to enable the 
development of highly organized striated muscle. These structural proteins include actin, alpha-
actin, myosin and titin. The precise mechanism is still largely unknown and different models 
of myofibrillogenesis have been described (Reviewed in 68. Most favourite model is currently 
the premyofibril model. This model proposes that premyofibrils act as a precursor of mature 
myofibrils. The premyofibril is a small sarcomere that contains sarcomeric proteins; actin, non-
muscle myosin II, troponins, tropomyosin and Z-bodies, which is enriched with alpha-actinin. 
Premyofibrils will align and grow by assembly of titin and muscle myosin II. The myofibril is 
now called nascent 69. In the transition from nascent to mature myofibril, the Z-bodies will form 
the Z-bands and the muscle myosin II will align into A-bands of the striated muscle. Although 
there is evidence in favour for this model, the precise mechanism of myotome formation is still 
unknown. 
2	The	FXR	protein	family
2.1 The FXR genes
The FXR genes are a small family of fragile X related genes, formed by FMR1, FXR1 and 
FXR2. In 1991, the FMR1 or Fragile X Mental Retardation 1 gene was found to be involved 
in the fragile X syndrome 70. The FMR1 gene is located at the long arm of chromosome X, at 
the position Xq27.3 71. FMR1 has a genomic sequence of 40 kb and is composed of 17 exons, 
encoding an mRNA of 3,9 kb 72. The two other members of the fragile X related family, FXR1 
and FXR2, are autosomal and map to chromosomes 3q28 and 17p13.1, respectively 73. The amino 
acid sequence homology between the corresponding FXR proteins is very high at the N terminal 
domain and central regions (figure 4). At the C terminal domain both FXR1 and FXR2 lack exon 
11 and 12 of the FMR1 gene 74. The high conservation of the gene structure among the three 
family members suggests that they may originate from a common ancestor gene 75.
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Indeed, Drosophila melanogaster appeared to have one gene representing all three homologues 
of the FXR genes 76,77. This will be described in more detail in chapter 2.5. 
In the 5’ untranslated region of the FMR1 gene a CGG trinucleotide repeat is located, which 
cannot be found in the other members of the fragile X related genes. The number of repeats in 
normal individuals is highly variable (5-50 repeats) with an average of approximately 30 CGGs 78. 
Normal alleles are stable upon transmission to the next generation 79. A repeat of 50 to 200 CGG 
repeats is called a premutation and can be instable upon transmission. Once the repeat exceeds 
the 200 CGGs, called a full mutation, the CGG repeats and the promoter region of the FMR1 
gene is usually methylated. Due to this methylation, FMR1 transcription is silenced and causing 
absence of the FMR1 gene product, the Fragile X Mental Retardation Protein (FMRP). The 
absence of FMRP in neurons is the cause of the mental retardation in fragile X patients 80,81. For 
both the FXR1 and FXR2 genes no human disease has been described so far. 
Figure	4. Schematic representation of the FXR protein family. The FXR proteins share a high homology, including the 
functional domains indicated by KH1, KH2 and RGG box. In the 5’UTR of the FMR1 gene, a CGG repeat is located, 
which normally varies between 5-50 repeats. A repeat size of 50-200 CGG repeats is called a premutation. If the 
repeat exceeds the number of 200,the FMR1 gene becomes inactivated and results in total lack of the FMR1 protein, 
FMRP. The lack of FMRP causes the fragile X syndrome
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2.2 Clinical features of the fragile X syndrome
Martin and Bell first described the fragile X syndrome, also known as the Martin-Bell 
syndrome, in 1943 82. Fragile X syndrome owns its name to a fragile site on the X chromosome 
that can be visualised in some cells of fragile X patients under specific culture conditions 83. 
With a prevalence of 1 in 4000 males and 1 in 6000 females, the fragile X syndrome is the most 
common form of inherited cognitive impairment. The fragile X syndrome has a wide range of 
clinical features, including moderate to severe mental retardation, macroorchidism and mild 
facial abnormalities, such as a long face, large everted ears and prominent jaws. In addition, 
many male patients exhibit autistic-like behaviour and other behavioural features like hand-
flapping, hand-biting and poor eye contact. More than 20% of male patients develop seizures, 
particularly during childhood 84. The molecular basis for the variability in the spectrum of 
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involvement is still largely unknown. Approximately 60% of females carrying a full mutation 
manifest learning disabilities, while the remaining 40% have normal intellectual capacity. For 
an extensive description of the phenotype of fragile X syndrome see thesis L.B.A. de Vries 3.
2.3 Unexpected phenotypes in FMR1 premutation carriers; FXTAS and POF
Individuals with a premutation, which ranges from 50 to 200 CGG repeats, were initially thought 
to be asymptomatic because they produce relative normal levels of FMRP. Research has shown 
that in cells of male premutation carriers FMR1 transcription is increased significantly, which 
results in elevated FMR1 mRNA levels 85,86. Typically, a 2-8 fold increase of FMR1 mRNA levels 
can be detected that seems to be positively correlated with the size of the CGG repeat. These 
elevated FMR1 mRNA levels have been proposed as the underlying molecular mechanism of 
a new neurological syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS), in older 
male premutation carriers (reviewed in 87,88). 
FXTAS is a neurodegenerative disorder, characterised by progressive intention tremor and 
ataxia, but also memory and executive impairment, essential tremor, autonomic dysfunction, 
parkinsonism, anxiety and peripheral neuropathy can be observed 89. The development of FXTAS 
in female premutation carriers is less evident than in males due to lyonisation in females.
The cause of FXTAS is still unclear. FMRP levels are mildly reduced, which led to the 
proposition that the CGG repeat in premutation individuals has become too long to be efficiently 
translated 85,86,90. The CGG repeat causes a conformational change that leads to hampering of 
the ribosome during translation 91. This leads to a reduced FMRP level, which in turn might 
activate a feedback mechanism to increase FMR1 transcription. Another explanation might 
be a conformational change in the promoter region that leads to enhancement of transcription. 
However, further investigations are needed to understand the development of FXTAS.
Neurohistological studies on brains of FXTAS patients revealed eosinophilic intranuclear 
inclusions in neurons and astroglia 92. These inclusions contain FMR1 mRNA and are ubiquitin 
positive, linking the increased FMR1 mRNA levels to the ubiquitin degradation pathway.  A 
toxic gain of function effect by the elevated level of FMR1 mRNA has been suggested to lead to 
formation of intranuclear inclusions.
On the other hand, nearly 20% of female premutation carriers manifest POF or premature 
ovarian failure, defined as menopause before the age of 40 93. A recent study reports early 
reproductive aging in regularly cycling premutation carriers 94. These findings suggest that 
ovarian dysfunction in premutation carriers is related to a decreased number of ovarian 
follicles compared to controls. The role of elevated FMR1 mRNA levels in the ovary and the 
development of POF in premutation carriers remain unclear. Importantly, POF and FXTAS are 
mechanistically distinct from the fragile X syndrome, that is, they are most likely caused by an 
RNA-gain-of-function whereas the fragile X syndrome is caused by a loss of function.  
2.4 FXR protein expression
The FXR gene family encodes the following proteins; FMRP, FXR1P and FXR2P. FMRP is 
maximally 632 amino acids long. Alternative splicing of exon 12, 14, 15 and 17 gives rise to many 
different isoforms of the protein 95. The FMRP isoforms have a molecular weight of 70-80 kDa 
and do not show a tissue-specific expression pattern 81. FMRP is expressed in a wide variety of 
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tissues with high expression in brain and testis. In the brain FMRP is expressed in differentiated 
neurons and concentrated in the perikaryon and the proximal dendrites. Most neurons of the 
brain show high labelling for FMRP, especially Purkinje cells and motorneurons. Generally, 
FMRP is localised in the cytoplasm, though nuclear localisation has been noted as well 96. In the 
cytoplasm FMRP is predominantly associated with actively translating ribosomes 97-100. Only 
a minority is present at synapses in the postsynaptic compartment 96,101 In primary neuronal 
cultures, FMRP could be detected in association with trafficking large mRNP particles involved 
in dendritic mRNA transport and translation 102,103 A recent study shows the presence of FMRP 
in the growth cones of developing axons in mature axons innervating dendrites (104 and Fallon 
unpublished results). The testis shows a high expression of FMRP with prominent labelling in 
early spermatogonia located at the basal membrane of the seminiferous tubules 105.
In different mammalian cell lines and in the majority of mouse tissues, FXR1P consists of 
four major isoforms with a molecular mass of 70, 74, 78 and 80 kDa. In muscle, these isoforms 
of FXR1P are absent, while two other isoforms of 82 and 84 kDa have been identified 106,107. 
In brain, FXR1P localisation is similar to FMRP, whereas FXR1P localisation in testis is not 
only restricted to early spermatogonia but is also localised in more mature spermatogenic 
cells including spermatocytes and spermatids 105. Furthermore, at the subcellular level 
FXR1P has been found to be associated with ribosomes and microtubules in the flagella of 
the spermatozoa 100,108. The muscle-specific isoforms were located to the costameric regions 
within the striated muscles 107,109.
Thus far only one isoform of FXR2P has been identified with a molecular weight of 95 kDa 105. 
FXR2P is co-expressed with FMRP and FXR1P in brain tissue and at least partly associated 
with ribosomes 100. In testis FXR2P is, although at low level, expressed in all spermatogenic 
cells of the tubules seminiferi 100,105. 
Notably, FMRP expression in brain tissue from fragile X patients is totally absent while FXR1P 
and FXR2P expression was identical compared to normal brain tissue 105. 
2.5 Orthologs of FXR genes
The FXR genes are highly conserved in evolution and orthologs of the human FMR1 gene have 
been identified in mouse Mus musculus, chicken Gallus gallus, fruitfly Drosophila melanogaster, 
frog Xenopus laevis and zebrafish Danio rerio 76,110-112. The overall homology between the 
functional domains indicates strong conservation of the FMR1 gene, thus, apparently its function 
during evolution seems to be conserved as well. In mouse and zebrafish all three members of the 
FXR genes have been identified. 
The three members of the FXR family in the mouse (Mus musculus) show high homology with 
the human FMR/FXR genes, except for exon 12, which is missing in mouse Fmrp. The murine 
homolog of FMRP has 97% homology 110. The chicken (Gallus gallus) homologue of FMR1 has 
nucleotide and amino acid identities with human FMR1 of 85 % and 92%, respectively 111. All 
three FXR members could be identified in zebrafish. The overall identities between human-
zebrafish, mouse zebrafish, frog-zebrafish and fruitfly-zebrafish Fmrp are 74%, 70%, 72% and 
38%, respectively 113. In the frog (Xenopus laevis) the amino acid sequence of Fmrp is 86% 
identical to the human FMRP over the entire length of the protein. For Xenopus tropicalis 
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this homology with the human FMRP is 76%. In X. tropicalis only an ortholog for FMRP and 
FXR1P could be identified. Both genes contain all functional domains 112.
Interestingly, the fruitfly (Drosophila melanogaster) contains a single, well-conserved dFxr 
gene representing all three homologues of the FXR gene family in mammals 76,77. The dFxr gene 
is homologous with all three FXR genes in human. The amino acid sequence of the KH domains 
is 85% homologous with human FMRP and also contains an RGG box. Even the subcellular 
localisation and the embryonic expression pattern are comparable to the expression pattern of 
FMRP in mammals 76. 
In Caenorhabditis elegans and Saccharomyces cerevisiae, two lower eukaryotes, no homologues 
of the human FMR1 could be identified 114,115. Therefore it was thought that the Drosophila 
melanogaster Fxr gene is some kind of ancestral gene, which evolved into the FXR genes 
in mammals. However, recently an FMR1 ortholog has been described in cnidarian hydroid 
Hydractinia echinata. An Fxr1 or Fxr2 ortholog could not be identified. Thus the origin of the 
FXR genes date back at least to a common ancestor of the cnidarians and bilaterans and that 
lack of FXR genes in invertebrates may have been due to gene loss in particular lineages during 
evolution 116. 
2.6 Fxr knockout mouse models
In order to study the physiological function of a protein, animal models can be of great help. 
The high evolutionary conservation of FXR proteins between the different species makes this 
possible. In these functional studies the laboratory mouse is often the mammal of choice because 
embryonic stem cells are available and manipulation of gene expression is to date a standard 
technology. Indeed, knockout mice for all three genes were generated and characterised.
The Fmr1 knockout mouse displays some characteristics in common with fragile X patients, 
including learning deficits and enlarged testis 117,118 for review. In addition, ultrastructural studies 
of the brain revealed the presence of abnormal dendritic spines illustrating reduced pruning 
and/or maturation of spines 104,119-121. Notably, spine abnormalities have already been reported in 
fragile X patients in earlier studies using brain autopsy material 122,123. The process of pruning 
spines, that are not frequently activated, and further maturation of spines occurs during early 
embryonic development and continues after birth. Thus, fragile X syndrome can be classified as 
a human developmental disorder.
The Fxr2 knockout mice show a discrete behavioural phenotype, like hyperactivity, impaired 
motor coordination, abnormal sensorimotor gating, and decreased response to heat stimulus and 
impaired learning and memory. Some features resemble the behavioural phenotype of the Fmr1 
KO mouse, while others are distinct for the Fxr2 KO mouse 124. Recently, an Fmr1/Fxr2 double 
knockout mouse was generated to better understand the function, interaction and possible 
compensation between Fmr1 and Fxr2. The Fmr1/Fxr2 double knockout mice appeared to have 
exaggerated behavioural phenotypes compared to the Fmr1 knockout mice and Fxr2 knockout 
mice. This suggests that FMRP and FXR2P have common functions in some behavioural 
responses 125.
Fxr1 knockout mice die shortly after birth and appeared to have a striated muscle phenotype. 
Macroscopic examination reveals that some organs of the Fxr1 knockout mice such as heart, 
skeletal muscle, lung, spleen and testis are less developed compared to wildtype mice and seem 
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to be missing large blood vessels at the surface of these organs. When examined microscopically 
they display a disruption of the cellular architecture of the striated muscle tissue. Due to loss 
of Fxr1p in the striated muscle, the costameric proteins vinculin, dystrophin and α-actinin are 
delocalised 109. The neonatal death of the Fxr1 KO mouse and the observed disruption of the 
cellular architecture of the striated muscle tissue illustrate the importance of Fxr1p during 
embryonic muscle development (figure 5). 
2.7 Function of FMRP
FMRP has been extensively studied due to its involvement in the fragile X syndrome. The 
precise physiological function of FMRP is still unclear; however, compelling evidence supports 
a role of FMRP in synaptic plasticity. FMRP contains a nuclear localisation signal (NLS) and 
a nuclear export signal (NES), which are involved in shuttling of FMRP between the nucleus 
and cytoplasm 126,127. Two hnRNP K homology domains (KH domains) and an arginin/glycin 
rich RNA binding motif (RGG box) have been identified within FMRP, which are motifs 
characteristic for RNA binding proteins 128,129. A missense mutation in the second KH domain 
(Ile304Asn) causes a severe form of the fragile X syndrome illustrating the importance of this 
domain 130. Searching for the target mRNAs for FMRP, a specific mRNA interaction motif was 
found in the RGG-box region. This high affinity-binding site for FMRP consists of a purine 
(G)-rich region that can fold into a tertiary structure, called the G-quartet structure. Also FMR1 
mRNA contains a G-quartet structure, which facilitates direct binding to FMRP 131. Microarray 
technique on immunoprecipitated RNP complex containing FMRP from human and mouse 
tissues identified 12 potential target mRNAs of which eight transcripts were capable of forming 
a G-quartet. Interestingly, some of these target mRNAs are important neuronal proteins, like 
semaphorin, NAP22 and MAP1B 132-134. Another RNA complex was identified as a target of the 
FMRP KH2 domain. This complex forms a stable loop-loop pseudoknot, or kissing complex 
(hence the name). In contrast to G-quartet RNAs, the kissing complex can compete with 
polyribosomes for the association of FMRP. RNAs within the kissing complex may play a role 
Figure	5. HE stained paraffin sections of neonatal WT (A) and Fxr1 knockout (B) cardiac tissue. The overall cellular 
architecture of the cardiac muscle from Fxr1 KO mice is disrupted.
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in FMRP translation control and thereby related to the mental retardation in fragile X syndrome 
and the severe form associated with the I304N mutation 135. An alternative target recognition 
mechanism has been proposed via a small non-translating RNA, named BC1. BC1-mediated 
recognition and translational control revealed Arc, MAP1B and α-CaMKII as potential target 
mRNAs for FMRP 136. 
More and more data reveal the involvements of FMRP in synaptic plasticity. The long thin and 
tortuous spines in Fmr1 KO mouse brains and correlated findings in Fragile X patients suggest 
that the lack of FMRP impairs maturation and pruning of spines 137,138. At postsynaptic dendritic 
sites, FMRP and FMR1 mRNA are also associated with polyribosomes 96,101. In addition, a 
subset of the identified FMRP interacting mRNAs appeared to encode for a neuronal protein 
found at the postsynaptic site or is isolated from synaptoneurosomes. These mRNAs include 
MAP1B, Arc, CaMKIIa and glutamate receptors 139-142. The observation of increased FMRP 
expression by activation of metabotropic glutamate receptor (mGluR) links FMRP to synaptic 
function 101. Finally, measurements of long-term depression (LTD) in Fmr1 KO mice showed an 
enhancement compared to wildtype mice. LTD is a long lasting decrease in synaptic connectivity, 
consistent with the role FMRP as a repressor of translation 143-145. This leads to a model that 
suggests that when mGluR receptors are activated local protein synthesis in the postsynaptic 
compartment is stimulated to maintain LTD by (permanent) internalisation of AMPA receptors. 
One of the proteins synthesized is FMRP, which in turn has a negative feedback on the local 
protein synthesis (repressor). This inhibition of translation by FMRP is required to control LTD. 
In case of the absence of FMRP an increase in protein level at the synapse and an increased LTD 
is observed 143.
Thus, FMRP plays an important role in selective targeting of a subgroup of mRNAs to dendrites 
in an inactive state and subsequent translational control at the synapse. In this way FMRP is 
essential for synaptic plasticity and thus for learning and memory processes (reviewed in 146). 
Misregulation or mistrafficking of FMRP-associated mRNAs is thought to be the underlying 
cause of the fragile X syndrome.
2.8 Possible functions of FXR1P and FXR2P
To date the cellular function of both FXR1P and FXR2P are less well understood. Sequence 
analysis of the FMRP homologues, FXR1P and FXR2P, show a high conservation, especially 
in the functional domains and an overlap in tissue distribution 73,74,100,105,147.  This suggests that 
FXR1P and FXR2P might have a similar function as FMRP in mRNA transport and translational 
control. Furthermore, all FXR proteins are associated with translating polyribosomes in the 
form of messenger ribonuclear particles (mRNP) 99,100. FMRP, FXR1P and FXR2P are able to 
form homo- and heteromeres in vivo 148. Apparently, FXR1P and FXR2P cannot completely 
compensate completely for the absence of FMRP in the fragile X syndrome. However, considering 
the importance of FMRP function in synaptic plasticity and the overall expression in brain 
tissue a more severe phenotype would be expected. The Fmr1/Fxr2 double knockout mouse 
shows that Fxr2p could compensate only part of the Fmrp function in behaviour. This indicates 
that FXR1P and FXR2P may have their own specific function. 125 For example, CYFIP2 binds 
to all FXR proteins compared to CYFIP1, which binds only to FMRP 149. 
As mentioned before all FXR proteins are expressed in the brain, however, they show distinct 
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localisation in the testis. FXR1P is the only family member expressed at high level in striated 
muscle tissue. 100,105-109). As a consequence the other two proteins are not capable to compensate 
for the loss of FXR1P in striated muscle. A study of an Fxr1 knockout mouse proposed a role 
for FXR1P in muscle mRNA transport/translation control and structural costameric mRNAs, 
particularly 109. A recent article describes Fxr1 knockdown experiments in Xenopus laevis. Fxr1 
knockdown in Xenopus showed a highly specific muscle phenotype. It is shown that Fxr1p 
regulates the somite formation in the frog and it is suggested that Fxr1p may be essential during 
the formation of functional muscle 150.
Although all FXR proteins bind RNA, associate with ribosomes and interact with each other 
and seem to play a role in translational inhibition and/or RNA transport, functional differences 
between FMRP and its homologues suggest that each protein does have its own tissue- or stage-
specific function as well.
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Abstract
The FXR gene family is composed of three members, FMR1, FXR1 and FXR2. The FMR1 gene 
is involved in the fragile X syndrome, whereas for the other two members no human disorder 
has been identified yet. An appropriate animal model to study in vivo gene function is essential 
to unravel the cellular function of the gene products FMRP, FXR1P and FXR2P, respectively. 
In Xenopus tropicalis both Fmr1 and Fxr1 were identified; however, unexpectedly Fxr2 not. 
Here we describe the characterisation of both Fmrp and Fxr1p in Xenopus tropicalis. Fmrp is 
expressed ubiquitously throughout the embryo during embryonic development, whereas Fxr1p 
shows a more tissue-specific expression particularly during late embryonic development. In adult 
frogs both proteins are highly expressed in most neurons of the central nervous system and in all 
spermatogenic cells in the testis. In addition, Fxr1p is also highly expressed in striated muscle 
tissue. Western blotting experiments revealed only one prominent isoform for both proteins 
using different tissue homogenates of adult frogs. Thus, for in vivo gene function studies this 
relative simple animal model may serve as a highly advantageous and complementary model.
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FMRP, FXR1P and FXR2P belong to a small family of fragile X-related proteins (FXR family). 
Absence of FMRP in neurons of the central nervous system is the cause of the fragile X syndrome, 
the most common inherited form of mental retardation in humans 1. The fragile X syndrome is 
a neurodevelopmental disorder characterised by immature dendritic spines and altered synaptic 
strength 2. The absence or dysfunction of both FXR1P and FXR2P has not yet been defined 
to a human disease; however, a function of FXR1P in striated muscle development has been 
suggested 3,4. The cellular function of FXR2P, like FMRP, seems to be related to learning 
processes 5. For all three genes mouse models have been generated and specific phenotypes 
have been reported 4-6. Unfortunately, in vivo gene function studies in mammalians, including 
mice, focusing on the period of embryonic development are difficult. As a first step to generate 
a more suitable vertebrate animal model to study the physiological function of the three Fxr 
genes during embryonic development an initial characterisation of the Fxr gene family has been 
performed in Xenopus tropicalis. Unlike the slow-growing, tetraploid Xenopus laevis, however, 
Xenopus tropicalis is diploid and has a relatively short (<5 months) life cycle.
A high level of sequence conservation of the FXR genes throughout various vertebrates (mouse, 
rat, zebrafish) has been demonstrated 7. This was used to screen the Sanger Institute X. tropicalis 
EST database with sequences from the human FXR family members to find orthologues of the 
X. tropicalis Fxr genes. Interestingly, only complete coding sequences for both XtFmr1 and 
XtFxr1 could be compiled from overlapping ESTs. Using the JGI X. tropicalis genome assembly 
release v3.0 which includes a total of 33,749 gene models at a coverage of 7.4X, combined with 
the Sanger Institute X. tropicalis EST database did not yield a potential XtFxr2 gene. Apparently, 
an ortholog of FXR2 is absent in this particular species. Figure 1a illustrates a comparison of 
human FMRP and FXR1P with the X. tropicalis Fxr-protein family.  Overall identities between 
human and X. tropicalis FMRP and between human and X. tropicalis FXR1P was 76% and 82%, 
respectively. Both X. tropicalis proteins contained the important functional domains, including 
the nuclear localisation signal (NLS), two KH domains, the nuclear export signal (NES) and an 
RGG box. The 63 amino acid region directly after the second KH domain that corresponds to 
exon 11 and 12 in human was missing from FMR1 in X. tropicalis, which is in accordance with 
earlier notions of FMR1 obtaining these sequences during mammalian evolution.  In contrast to 
mouse, both human and X.  tropicalis  show the presence of the largest transcript containing the 
51 basepairs of exon 17. Interestingly, no CGG repeats were found in the 5’ UTR sequences of 
the XtFmr1 gene. CGG repeat expansion to over 200 units is the mutational mechanism found 
in the vast majority of fragile X patients. In addition, a phylogenetic analysis was performed, 
including human, mouse, zebrafish and frog proteins. A clear clustering of the respective X. 
tropicalis proteins with their predicted orthologues could be demonstrated (Figure 1b). There 
is no indication for a separate development of the X. tropicalis Fxr family. The similar branch 
evolution of the three clusters makes an absence of XtFxr2p unexpected.  Further Blast search 
through the JGI X. tropicalis genome database version 2.0 with the longest coding sequences 
for both XtFmr1 and XtFxr1 revealed the genomic structure of both genes. Alignments of 
these virtual gene structures with known human/mouse data showed a 100% identical exonic 
structure (data not shown).
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Figure	1A.	Amino	acid	sequence	alignment	of	X. tropicalis Fmrp	and	Fxr1p	with	their	human	orthologues. 
Identical residues are shaded in black and conserved substitutions in grey. The alignment shows highly homologous 
regions of both Fmrp and Fxr1p between human and X. tropicalis. All orthologues contain two KH domains, a nuclear 
localisation signal (NLS), a nuclear export signal (NES) and an RGG box. In addition, the peptide sequence of the 
epitopes of the antibodies are depicted.
Figure	1B.	Phylogenetic	analysis	of	the	Fxr	
gene	 family	members	 for	 	 human	 (FXR),	
mouse	 (Fxr),	 zebrafish	 (drFxr)	 and	 frog	
(XtFxr). 
The early evolutionary origin of this family is 
indicated by the Fmr1 like genes from Ciona, 
Hydractinia (hyFmr1) and fruitfly (dFmr1)
drFmrp
drFxr1p
Fmr1p
Fxr1p
FMRp
Fmrp
XtFmrp
XtFxr1p
drFxr2p
FXR2p
Fxr2p
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Protein expression studies were performed with specific antibodies against both Fmrp and 
Fxr1p. First, transfection studies were performed to study the occurrence of cross-reactivity 
of our antibodies between the different Fxr-proteins. Both proteins share a high homology 
and knockout tissue from frogs is not available, thus, HEK293T cells were transfected with 
an expression construct containing either XtFmr1 or XtFxr1 preceded by an EGFP sequence. 
Expression of the construct was monitored by the presence of green fluorescent HEK293T 
cells. For the two fusionproteins (EGFP-Fmrp and EGFP-Fxr1p) no cross-reactivity with our 
antibodies could be observed (Figure 2). 
Figure	2.	Specificity	of	antibodies	KI	and	3FX	against	XtFmrp	and	XtFxr1p,	respectively.
GFP signal in HEK293T cells that were transfected with either XtFmr1-EGFP (a and g) or XtFxr1-EGFP (c and e). Cells 
were simultaneously stained immuno-cytochemically (red) using either antibody KI (b and d) or 3FX (f and h). Specific 
labelling of antibody KI was only observed in the XtFmr1-EGFP transfected cells (b). The absence of KI positive-
labelling in the XtFxr1-EGFP transfected cells (d), indicates lack of cross-reaction of this antibody with Fxr1p. Similarly, 
antibody 3FX shows only a specific labelling with Fxr1p (f) and no cross-reactivity with Fmrp (h).
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Antibody KI specifically recognized Fmrp in HEK293T cells transfected with the EGFP-Fmr1 
expression construct (Figure 2b; red), whereas Fxr1p labelling was totally absent in HEK293T 
cells expressing EGFP-Fxr1p (Figure 2d). Similar results were obtained with antibody 3FX 
against Fxr1p. Figure 2f (red) illustrates the presence of Fxr1p with antibody 3FX using expression 
construct EGFP-Fxr1 and the lack of cross-reactivity with EGFP-Fmrp using construct EGFP-
Fmr1(Figure 2h).
Next, the cellular distribution of Fmrp was studied in embryonic stages and adult frogs using an 
indirect immunoperoxidase technique (Figure 3). 
Figure	3.	Fmrp	distribution	in	X. tropicalis	embryos	and	adult	frogs	using	antibody	KI.
Fmrp staining is present in the nuclei in stage 6 (a). The cells composing the animal pole show the typical large nucleus. 
At stage 23, when internally segregation of the brain occurs, Fmrp expression is evenly distributed in the cytoplasm of 
most cells (b). At stages 37 (c) and 46 (d), Fmrp expression remains ubiquitous with high expression in the eye, brain, 
intestine and skeletal muscle tissue. In contrast, adult X. tropicalis show a tissue-specifc expression pattern with high 
expression in the cytoplasm of most neurons in the brain (e) and all the spermatogenic cells of the testis (f). Note the 
absence of Fmrp in skeletal muscle (g).
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Paraffin sections of embryos at stages 6, 23, 37 and 46 of development representing 2hrs, 1d, 2d 
and 7d after fertilisation, respectively, were studied. Fmrp showed a nuclear staining at 2 hours 
post fertilisation (2 hpf; Figure 3a) that changed to a cytoplasmic labelling throughout all cells 
in the later stages (Figures 3b-3d).
In adult frogs, Fmrp distribution showed a tissue-specific pattern. Fmrp was abundantly present 
in the cytoplasm of most neurons in the brain (Figure 3e) and in all the spermatogenic cells 
of the testis (Figure 3f). Notably, Fmrp could not be detected in striated muscle tissue (Figure 
3g for skeletal muscle). Our results for embryonic Fmrp expression in X. tropicalis are not 
completely in line with previous reports on mouse and zebrafish expression patterns that showed 
Figure	4.	Fxr1p	distribution	in	X. tropicalis	embryos	and	adult	frogs	using	antibody	3FX.
Fxr1p staining is detected in the nuclei of pre MBT cells (a, (=morula); stage 6). At stage 23, high Fxr1p expression is 
predominantly present in structures  that will develop into muscle and brain tissue (b), although a weak labelling is 
also present in the other cell types. At stages 37 (c) and 46 (d), Fxr1p shows a tissue-specific expression pattern with 
a high expression in myoblasts of muscle tissue and neurons of the brain. The inset in (d) shows a high magnification 
of Fxr1p labelled myoblasts. In adult X. tropicalis , Fxr1p expression is defined to the cytoplasm of neurons in the 
brain (e) and all the spermatogenic cells in the testis (f). In addition, a granular labelling pattern is observed in skeletal 
muscle tissue (g).
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an overall expression during very early embryonic development that became tissue-specific 
at later stages 8(van’t Padje, personal comm.). Apparently, the tissue-specific Fmrp expression 
in frogs occurs later in development compared to mouse and fish. Interestingly, the nuclear 
distribution of Fmrp during very early development (2 hpf) has been described for zebrafish as 
well (van’t Padje, personal comm.). In adult frogs, a similar tissue-specific expression of Fmrp 
in brain and testis has been reported in human, mouse and fish. However, the presence of Fmrp 
in all spermatogenic cells of the testis has not been observed in the other vertebrates that showed 
only Fmrp expression in spermatogonia at the basal membrane of the seminiferous tubules 8,9.
In contrast, Fxr1p distribution shows a more tissue-specific pattern during embryonic 
development. At a very early stage (2 hpf), Fxr1p showed a nuclear staining like Fmrp (Figure 
4a). However, at stage 23 when internally segregation of the brain occurs a spatial organisation 
of Fxr1p developed more preferentially in structures that will develop into muscle (mesodermal) 
and neural (ectodermal) tissue (Figure 4b). From stage 37 onwards a further tissue-specific 
expression was observed with a high expression in the cytoplasm of neurons and skeletal muscle 
tissue (Figure 4c-4d). In adult frogs, Fxr1p distribution remained tissue-specific. A strong 
labelling is observed in the cytoplasm of neurons (Figure 4e), all the spermatogenic cells of the 
testis (Figure 4f) and skeletal muscle tissue (Figure 4g).  This Fxr1p expression pattern during 
embryonic development and adult stages showed high similarities with the expression patterns 
described for man, mice and fish 3,7,9,10.
Figure	 5.	 Western	 blot	 analysis	 of	 adult	
X. tropicalis	 tissues	 using	 antibodies	 KI	 (a)	
and	3FX	(b).
In homogenates from brain (a; lane B) and testis (a; 
lane T) a single isoform of approximately 72kDa 
could be detected. Importantly, homogenates 
of HEK293T cells transfected with XtFmr1-EGFP 
showed a prominent band representing the Fmrp-
EGFP fusion protein of approximately 99 kDa (a; 
lane 2), whereas transfection with XtFxr1-EGFP 
did not results in any detectable isoform (a; lane 
1). For Fxr1p, a weak band of approximately 80 
kDa could be detected in brain (b; lane B) and in 
testis this band was more prominent (b; lane T). 
In skeletal muscle homogenates a single isoform 
of approximately 84 kDa appeared (b; lane M). 
The specificity of antibody 3FX is illustrated by 
the detection of the Fx1p-EGFP fusionprotein 
in XtFxr1-EGFP transfected HEK293T cells with 
a size of approximately 107 kDa (b; lane 1) and 
the absence of any isoform in XtFmr1-EGFP 
transfected HEK293T cells (b, lane 2).
Both Fmrp and Fxr1p share the nuclear labelling during very early development, which suggests 
a specific nuclear function during this short period of development. Most likely, translation of 
maternally provided transcripts account for these gene products. The high expression of Fxr1p 
in skeletal muscle tissue at late embryonic stages and in adult frogs suggests a role for Fxr1p 
in myogenesis. Similar to striated muscle tissue from mouse and zebrafish, the characteristic 
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granular labelling of Fxr1p present in skeletal muscle from frogs suggests that Fxr1p is located 
in specific structures of the muscle tissue, called costameres 3,4,7. 
In man and mice, different isoforms of Fxr1p have been described for the different tissues, due 
to alternative splicing 8-11. In contrast, Fmrp isoforms were identical for all the different tissues 
tested, that is, the presence of four major isoforms. Here, Western blotting was performed to 
study the presence of specific isoforms in frog tissues. Using antibody KI, against Fmrp, only 
one major isoform of 72 kDa could be detected in both brain and testis tissue from X. tropicalis. 
As a control, homogenates from HEK293T cells transfected with an expression construct 
containing EGFP-Fmr1 or EGFP-Fxr1 were incubated with antibody KI. The lane loaded with 
the homogenate containing EGFP-Fmrp fusion proteins revealed a band of 99 kDa (72kDa for 
Fmrp and 27 kDa for EGFP), whereas the other lane loaded with EGFP-Fxr1p fusion proteins 
was totally devoid of specific isoforms (Figure 5a). Antibody 3FX, against Fxr1p, showed the 
presence of a single molecular form of approximately 80 kDa in homogenates from both brain 
and testis tissue. In skeletal muscle tissue Fxr1p is present as a prominent single isoform of 
approximately 84 kDa. The specificity of the 3FX antibody was illustrated by the presence and 
absence of cross reactive material in the lane loaded with a homogenate from HEK293T cells 
transfected with XtFxr1 and XtFmr1, respectively (Figure 5b). These results demonstrate that X. 
tropicalis expresses fewer Fxr isoforms compared to man and mice.
In conclusion, we report here the characterisation of Fmrp and Fxr1p in Xenopus tropicalis. 
Both proteins share the major functional domains with their murine and human orthologues 
and show a differential expression pattern. Importantly, the tissue-specific expression of both 
proteins in adult frogs is comparable to the other vertebrate systems; however, the number of 
isoforms is restricted to one major isoform, which makes this model more simple to study in 
vivo gene function. Additionally, Xenopus is a widely used developmental model organism with 
a fast external (transluscent) development, many eggs per breeding and the recent development 
of novel gene knockdown technology using the morpholino strategy. All together, this makes 
X. tropicalis an attractive complementary model system to study the physiological function of 
Fmrp and Fxr1p, especially during embryonic development.
Experimental	procedures
Xenopus tropicalis were obtained from the Hubrecht laboratory, Utrecht and originate from a 6th 
generation Nigeria inbred line. Methods of egg collection, fertilisation, and embryo culture were 
as described 12. Developmental stages were assigned according to Nieuwkoop and Faber 13.
The Sanger Institute Xenopus tropicalis EST database was searched for orthologues (www.
sanger.ac.uk/Projects/X. _tropicalis/).
Sets of oligo nucleotide primers were designed and used to extract mRNA sequences by RT-
PCR from either adult brain for XtFmr1 or whole embryos, stage 37. For XtFxr1 adult skeletal 
muscle was used. 
Phylogenetic analysis has been performed using the Treetop phylogenetic tree prediction program 
from GeneBee Services (http://www.genebee.msu.su)Rabbit antibody KI was raised against 
the C-terminus of FMRP 14,15 while monoclonal 3FX antibody was raised against a synthetic 
polypeptide that was common to the long and short isoforms of FXR1P 10. HEK293T cells were 
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transfected with lipofectamine PLUS according to the manufacturer. For immunofluorescence 
analysis of transfected cells either an anti-rabbit or anti-mouse secondary antibody conjugated 
with TRITC was used. The details of the Western blotting procedure and the indirect immuno-
peroxidase method on paraffin sections has been described before 8.
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Abstract
Fragile X syndrome is the most common inherited form of mental retardation. It is caused by the 
lack of the Fragile X Mental Retardation Protein (FMRP), which is encoded by the FMR1 gene. 
Although Fmr1 knockout mice display some characteristics also found in fragile X patients, 
it is a complex animal model to study brain abnormalities, especially during early embryonic 
development. Interestingly, the ortholog of the FMR1 gene has been identified not only in mouse, 
but also in zebrafish (Danio rerio). In this study, an amino acid sequence comparison of FMRP 
orthologs was performed to determine the similar regions of FMRP between several species, 
including human, mouse, frog, fruitfly and zebrafish. Further characterisation of Fmrp has been 
performed in both adult and embryos of zebrafish using immunohistochemistry and Western 
blotting with specific antibodies raised against zebrafish Fmrp. We demonstrated a strong Fmrp 
expression in neurons of the brain and only a very weak expression in the testis. In brain tissue, 
a different distribution of the isoforms of Fmrp, compared to human and mouse brain tissue, 
was shown using Western blot analysis. Due to the high similarity between the zebrafish Fmrp 
and the human FMRP and their similar expression pattern, the zebrafish has great potential as 
a complementary animal model to study the pathogenesis of the fragile X syndrome, especially 
during embryonic development.
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Introduction
With a prevalence of 1 in 4000 males and 1 in 6000 females, the fragile X syndrome is the most 
common form of inherited mental retardation in man. Main characteristics are mild to severe 
mental retardation, macroorchidism, autistic-like behaviour and mild facial features 1. Fragile 
X syndrome is caused by the lack of the Fragile X Mental Retardation Protein (FMRP), which 
is encoded by the FMR1 gene. The most common mutation in individuals with the fragile X 
syndrome is an expansion of a CGG trinucleotide repeat in the 5’ untranslated region of the 
FMR1 gene that exceeds 200 units (full mutation). As a consequence the promoter region of 
the FMR1 gene, including the CGG-repeat, is methylated and FMR1 transcription is repressed, 
which leads to the absence of the protein product of the FMR1 gene 2,3.
The FMR1 gene, together with the two autosomal homologues, FXR1 and FXR2, forms a 
small family of fragile X related genes. All three proteins contain a nuclear localisation signal 
(NLS), two KH (hnRNP K homology) domains, a nuclear export signal (NES) and an RGG box 
(arginine-glycine-glycine tripeptide repeat)4,5. In human, FMRP is highly expressed in neurons 
of the brain and early spermatogonia in the testis 6,7. At the subcellular level, FMRP is present in 
mRNP (messenger ribonucleoprotein) particles associated with actively translating ribosomes 
8-11. The precise cellular function of FMRP is still unclear; however, FMRP has been proposed to 
play a role in the regulation of transport/translation of a subset of dendritic mRNAs, containing 
a G-quartet. 12-16. In neurons, selective targeting to dendrites and subsequent translation of 
specific mRNAs plays an important role in synaptic plasticity and is essential for learning and 
memory processes (reviewed Willemsen et al., 2004). Misregulation or mistrafficking of FMRP 
associated-mRNAs is thought to be the underlying cause of the fragile X syndrome.
Orthologs of the human FMR1 gene have been identified in mouse Mus musculus, fruitfly 
Drosophila melanogaster, frog Xenopus laevis and zebrafish Danio rerio. The overall similarity 
between the functional domains indicates strong conservation of the FMR1 gene, thus, apparently 
its function during evolution seems to be conserved as well. In mouse, frog and zebrafish all 
three members of the FXR genes have been found. Interestingly, the fruitfly contains a single, 
well-conserved dFXR gene representing homologues of the three FXR-gene family members 
in mammals 17,18. Very recently, the transcription of the zebrafish FXR family members was 
shown to be consistent with the expression pattern in mouse and human using whole mount in 
situ hybridisation (Tucker et al., 2004). In addition, Engels et al. showed tissue-specific Fxr1p 
expression in skeletal muscle and brain of adult zebrafish at the translational level (Engels et 
al., 2004).
In order to study the pathogenesis of the fragile X syndrome and the physiological function of 
FMRP, an Fmr1 knockout mouse has been generated. This mouse displays some characteristics 
in common with fragile X patients, including learning deficits and enlarged testis 19. In addition, 
ultrastructural studies of the brain revealed the presence of abnormal dendritic spines illustrating 
reduced pruning and/or maturation of spines 20-22. Notably, spine abnormalities have already been 
reported in fragile X patients in earlier studies using brain autopsy material 23,24. Compelling 
evidence suggests that these spine abnormalities result in altered synaptic development and 
plasticity and this is the proposed basis of mental retardation in fragile X syndrome. The process 
of pruning spines, that are not frequently activated, and further maturation of spines occurs 
during early embryonic development and continues after birth. Thus, fragile X syndrome can 
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be classified as a human developmental disorder. In order to study the involvement of FMRP in 
the processes during (very) early embryonic development a more advantageous animal model 
than the mouse has been considered, that is, the zebrafish. 
Here, we report the characterisation of Fmrp in both adult and embryonic stages of the zebrafish, 
including nucleotide sequence analysis, cellular distribution and detection of tissue specific 
isoforms using specific antibodies raised against zebrafish Fmrp.
Materials	and	Methods
Zebrafish
Zebrafish line was obtained from the Wageningen ZF WT Zodiac F5 line. Fish were kept at 
25°C in a 12-hour light/dark cycle and fed artemia 3 times a day.  Zebrafish embryos were 
collected from spontaneous spawning. 
Amino acid sequence alignment
The amino acid sequences of FMRP from human, mouse, fruitfly and frog were taken from the 
Genbank database of NCBI.  The accession numbers used for the alignment are NP_002015, 
NP_032057, NP_611645 and AAC59683, respectively. The accession number of zebrafish Fmrp 
is NP 694495. For retrieval of the zebrafish amino acid sequence of Fmrp, the zebrafish Ensembl 
Genome Browser has been used (Ensembl translation ID: ENSDARP00000031163). 
 
Zebrafish Fmrp specific antibody
A rabbit polyclonal antibody specific against zebrafish Fmrp (758) was purchased from 
Eurogentec according to the double X program (Herstal, Belgium). A synthetic peptide, 
SKLRPQEESRQIRID, was designed from the C-terminal end of the Fmrp protein, because of 
the low similarity in this part between the fxr genes. The antibody (named 758) against Fmrp 
was affinity purified against the synthetic peptide and used 1: 400 for immunohistochemistry 
and 1:4000 for Western blotting. 
Zebrafish fxr-EGFP constructs
Total RNA was isolated from adult brain tissue and cDNA was synthesized 
using random hexamers and oligo dT. Amplification of fmr1 was performed with 
the following PCR primers: 1F 5’-CGCTAGAATTCAATGGACGAG-3’ and 
1R 5’-TGAATTCTAGCGCTACGAAAC -3’. Both primers contain an EcoRI restriction site and 
are located at the start- and stopcodon, respectively. The PCR product was digested with EcoRI 
and cloned into pEGFP-C1 vector from Clontech. For fxr1-EGFP and fxr2-EGFP constructs, see 
Engels et al. 25. All constructs were sequence verified.
Cell culture and transfection
COS-1 cells were maintained in DMEM (Gibco) supplemented with 10% foetal calf bovine 
serum (Gibco) and kept at 37 °C in a 5% CO
2
 atmosphere. A day before transfection, cells 
were seeded on cover slips in a 24-wells plate at low density. Transfection with fmr1-EGFP, 
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fxr1-EGFP and fxr2-EGFP constructs has been performed according to the manufacturers 
instructions using Lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection, cells 
were fixed with 4% paraformaldehyde for 10 min. at room temperature, followed by a 100% 
methanol step for 20 minutes. Cells were immunostained with rabbit primary antibody 758 
(see above) and subsequently with goat anti-rabbit immunoglobulins conjugated with TRITC 
(Nordic, Tilburg, The Netherlands).
Immunohistochemistry 
Zebrafish were euthanized in tricaine (3-amino-benzoic ethylester, Sigma, 25g/l), fixed with 
4% paraformaldehyde, decalcified with EDTA and embedded in paraffin. Embryos were 
harvested at 3, 6, 12 and 24 hpf, fixed with 4% paraformaldehyde and embedded in paraffin. 
Sections (5µm) were deparaffinized, rehydrated and microwave-treated according to standard 
protocols 26. Briefly, endogenous peroxidase activity was inhibited by 30 min. incubation 
in PBS-hydrogen peroxide-sodium azide solution (100 ml 0.1 M PBS + 2 ml 30% H
2
O
2
 + 1 
ml 12.5% sodium azide). Sections were incubated with primary antibody 758 for 1.5 hour at 
room temperature. Subsequently, a 1-hour incubation with a peroxidase conjugated secondary 
antibody was performed. For signal detection 3,3, di-amino-benzidine was used as a substrate 
(DAKO). Sections were counterstained with hematoxylin and mounted with Entellan (Merck).
Western blot analysis
Zebrafish tissues (brain, testis and skeletal muscle) and transfected COS cells were homogenized 
in Hepes buffer (10mM Hepes, 300mM KCL, 5mM MgCl2, 0.45% Triton, 0.05% Tween, pH 
7.6) containing Complete protease inhibitor cocktail (Roche), sonicated and centrifuged for 10 
minutes at 10.000 rpm and 4°C. Protein concentrations were determined and equal amounts 
of protein were applied per lane. Proteins were separated on an 8% SDS-PAGE gel and were 
electroblotted onto nitrocellulose membrane (Schleicher & Schuell). Immunodetection was 
carried out using the zebrafish Fmrp specific antibody 758. The secondary antibody (goat anti-
rabbit Igs; 1:5000) conjugated with peroxidase allowed detection with the chemiluminescence 
method (ECL KIT, Amersham). 
Results
High similarity between orthologs of FMRP
The amino acid sequence alignment of FMRP from human, mouse, frog, zebrafish and fruitfly 
revealed high conservation at the N-terminal part and showed lesser similarity at the C-terminal 
part of the protein (figure 1). Overall identities between human-zebrafish, mouse-zebrafish, frog-
zebrafish and fruitfly-zebrafish Fmrp are 74%, 70%, 72% and 38%, respectively. All proteins 
contained the important functional domains, including the nuclear localisation signal (NLS), 
two KH domains, the nuclear export signal (NES) and an RGG box. The 63 amino acid region 
directly after the second KH domain that corresponds to exon 11 and 12 in human was missing 
in frog, fruitfly and zebrafish. Considering the mRNA no CGG repeats were found in the 5’ 
UTR sequences of the zebrafish fmr1 gene, which is similar to frog and fruitfly. 
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Figure	1.	Amino	acid	sequence	alignment	of	FMR1	proteins	(Fmrp)	of	several	species.
Identical residues are shaded in black and conserved substitutions in grey. The alignment shows highly homologous 
regions of Fmrp between human, mouse, frog, fruitfly and zebrafish. All orthologs contain the nuclear localisation 
signal (NLS), two KH domains, nuclear export signal (NES) and an RGG box.
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Specificity of the polyclonal antibody against zebrafish Fmrp
The antibody 758 against zebrafish Fmrp has been developed against the C-terminal part of 
the protein, since similarity to the fxr proteins is low in that part of Fmrp (figure 1). To test the 
specificity of the antibody 758, COS cells have been transfected with fmr1-EGFP, fxr1-EGFP 
and fxr2-EGFP constructs and analysed by immunofluorescence microscopy using antibody 
758. Using the fmr1-EGFP construct, a strong overlapping signal is observed for both the GFP-
fluorescence and staining with antibody 758 (figures 2a and 2b, respectively). On the other hand, 
in both fxr1-EGFP (figures 2c and 2d) and fxr2-EGFP (figures 2e and 2f) transfected cells only 
a clear GFP signal could be detected (figures 2c and 2e, respectively), whereas staining with 758 
antibody showed a total lack of fluorescence signal. This demonstrates the absence of cross-
reactivity of antibody 758 with Fxr1p-EGFP and Fxr2p-EGFP fusion protein (figures 2d and 2f, 
respectively).
Western blotting analysis of the fmr1-EGFP transfected COS cells homogenate shows a band of 
approximately 100 kDa, that corresponds to the expected size of the Fmrp-EGFP fusion protein 
(figure 2g lane 1; 27 kDa for EGFP and 73 kDa for Fmrp). In cell homogenates from COS 
cells overexpressing either Fxr1p-EGFP or Fxr2p-EGFP fusion proteins no cross-reactivity with 
antibody 758 could be detected (figure 2g, lane 2 and 3, respectively).
Figure	2.	Specificity	of	antibody	758	against	
zebrafish	Fmrp.
GFP signal in COS cells that were transfected 
with fmr1-EGFP (a), fxr1-EGFP (c) and fxr2–
EGFP constructs (e). Cells were also stained 
immunocytochemically using antibody 758 against 
zebrafish Fmrp. Specific labelling by antibody 758 
is only observed in the fmr1-EGFP transfected 
cells (b). The absence of 758-labelling in both 
the fxr1-EGFP and fxr2–EGFP transfected cells, 
indicates lack of cross-reaction of antibody 758 
with either Fxr1p or Fxr2p (d and f). Western blot 
analysis of homogenates of the fmr1-EGFP, fxr1-
EGFP and fxr2–EGFP over expressing COS cells 
(g, lanes 1, 2 and 3, respectively), only shows a 
band in lane 1, confirming these results.
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Localisation of Fmrp in adult and embryonic tissues of zebrafish
The expression pattern of Fmrp in adult and embryos of zebrafish was analysed by 
immunohistochemistry on paraffin sections using antibody 758. At three hours post fertilisation 
(hpf), Fmrp was ubiquitously expressed throughout the embryo (figure 3a). Note the nuclear 
staining in the 3 hpf embryos (figure 3b, arrows(. This ubiquitous expression continued in the 
embryos at the 6, 12 and 24 hpf stages  (figure 3c+d, 3e-f and 3g, respectively). However, in 72 
hpf embryos the Fmrp expression became more tissue-specific, that is, restricted to neurons 
from the brain (figure 3h) and spinal cord(figure 3i), and from 48hpf onwards no expression in 
skeletal muscle could be observed (for 72hpf; figure 3ih). 
Figure	3.	Immunohistochemistry	on	zebrafish	embryos	using	antibody	758.
In 3 hours post fertilisation (hpf) (a and b), 6hpf (c and d), 12 hpf(e and f) and 24 hpf (g) embryos, Fmrp was ubiquitously 
expressed throughout the embryo. Note the nuclear staining in cells of the 3 hpf embryo (b, arrows). In 72 hpf (h and 
i) embryos Fmrp expression was restricted to neurons throughout the brain and spinal cord (s), however, skeletal 
muscle (m) was totally devoid of Fmrp. A dorsal view of the brain of a 72 hpf embryo is shown in (h); the inset shows 
a higher magnification of the indicated region of the brain. d= diencephalon
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Figure	4.	Immunohistochemistry	on	adult	tissues	of	zebrafish	using	antibody	758.	
In adult zebrafish tissues, high Fmrp expression could be detected in all the neurons throughout the brain. Here we 
show, as an example, Fmrp expression in Purkinje cells of the cerebellum (arrows). In testis, a very weak labelling 
is observed in immature sperm cells (c; arrows; s= mature sperm cells). In skeletal muscle no Fmrp signal could be 
detected (d; m= skeletal muscle).
Figure	5.	Western	blot	analysis	of	different	adult	
zebrafish	tissues.
In brain homogenates a very prominent isoform of 75 
kDa is present using antibody 758. In addition, a very 
weak band of 71 kDa could be detected. In skeletal 
muscle and testis, no isoforms could be detected.
 
A comprehensive analysis of the different tissues of the adult zebrafish revealed that Fmrp 
expression was present in all the neurons of the brain, including telencephalon, diencephalon, 
metencephalon and spinal cord. An example of high Fmrp expression in the Purkinje cells 
of the cerebellum is shown in figures 4a and 4b. In sections of the testis, only a very weak 
signal could be observed in immature spermatogenic cells, including spermatogonia and early 
spermatocytes (figure 4c). No labelling was observed in skeletal muscle (figure 4d).
Detection of isoforms in adult zebrafish tissues
Immunoblot analysis of total protein of brain, skeletal muscle and testis from adult zebrafish has 
been performed using the antibody 758. For brain, a prominent and a much weaker band were 
observed of approximately 75 kDa and 71 kDa, respectively. For skeletal muscle and testis, no 
Fmrp isoforms could be detected (figure 5).
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Discussion
After identification of the FMR1 gene as the gene involved in fragile X syndrome, fundamental 
research focused on the cellular function of the gene product,  FMRP. A logical tool in these 
studies was the use of a mammalian model system, including the generation of an animal model 
representing all the aspects of the human disease. Thus far, often the mouse is the animal 
of choice because genetic modification of the genome of the mouse is a rather established 
technology. In addition, the availability of many different behavioural tests to study cognitive 
functions makes the mouse a valid animal model for further studies to unravel the pathogenesis 
of the fragile X syndrome. Indeed, the fragile X knockout mice show both learning deficits and 
macroorchidism, illustrating similarities between fragile X patients and this mouse model 19. 
Interestingly, morphological spine abnormalities and delayed maturation of spines were already 
present directly after birth in Fmr1 knockout mice 20,21. We looked for an alternative animal 
model system that would allow easy access to embryos and we propose here the zebrafish 
(Danio rerio) as a new complementary animal model system to study Fmrp function during 
(early) embryonic development.  Importantly, zebrafish possess all three fxr genes showing 
very similar amino acid sequence patterns compared with humans and mice. Here we report the 
initial characterisation of zebrafish Fmrp to establish it as a model for functional studies.
The presence of the same functional domains within FMRP between the different orthologs 
indicates preservation of its function. Comparison of the FMR1 amino acid sequences of human, 
mouse, frog and fruitfly revealed strong similarity, especially at the N-terminal part of the 
protein. This confirms the high degree of evolutionary conservation of the FMR1 gene 27,28. 
We raised a specific antibody (758) against zebrafish Fmrp to study the expression pattern and 
the presence of the different molecular isoforms in several tissues of both adult and embryos 
of zebrafish. The specificity of the antibody has been demonstrated in transfection experiments 
with constructs containing the different fxr gene using COS cells. No cross-reactivity was 
found with its homologs, Fxr1p and Fxr2p. Western blotting analysis confirmed this specificity 
for Fmrp. Immunohistochemical studies with antibody 758 showed that in early stages of 
embryonic development Fmrp is ubiquitously expressed in all cells using paraffin sections of 
zebrafish embryos. However, during the very early period of embryonic development (3hpf) 
Fmrp labelling was not only observed in the cytoplasm, but also present within the nucleus 
where it showed a random distribution. Thus far, a nuclear distribution of FMRP has been 
demonstrated only in transfected COS cells and in some neurons of adult murine brain 9,26. In 
addition, small amounts of FMRP were present in the nucleus after leptomycin B treatment of 
transfected COS cells 29. It has been suggested that FMRP shuttles between the cytoplasm and 
the nucleus in a regulated manner using a nuclear localisation signal (NLS) and nuclear export 
signal (NES), two functional domains present within the protein 5. Apparently, this specific 
function of Fmrp is more prominent during this early period of embryonic development. After 
72 hours of development, Fmrp expression is restricted to neurons in the brain and spinal cord, 
illustrating a change from an ubiquitous expression to a more tissue-specific expression pattern 
at this developmental stage. This phenomenon has been found during embryonic development of 
the mouse as well 30. In a recent study Tucker et al. described the expression of the three zebrafish 
orthologs of the FXR family using whole mount in situ hybridisation. During early embryonic 
development (0-12 hpf) fmr1 transcripts were distributed ubiquitously with a higher expression 
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in the anterior of the embryo. At 18 hpf fmr1 expression was at a low level, whereas at 24 hpf a 
high fmr1 expression was present in the brain (Tucker et al., 2004). Although our present study 
focused on expression of Fmrp at the protein level and not on fmr1 transcripts the results of both 
studies are consistent. We could not demonstrate a higher Fmrp expression in the anterior of 
the embryo at 12 hpf; however, this can be explained by differences in half-life between fmr1 
mRNAs and Fmrp. Furthermore, the presence of high quantities of mRNAs doesn’t necessary 
implicate the (immediate) translation of these mRNAs in proteins. We propose that during early 
embryonic development fmr1 mRNAs, of presumably maternal origin, are responsible for the 
ubiquitous expression of Fmrp and that the tissue-specific expression in later stages and adult 
zebrafish is the result of tissue-specific transcription.
Although FMRP is widely expressed, the localisation of high quantities of FMRP has been 
restricted to most neurons of human and mouse adult brain and spermatogonia within the testis 
6,7,26. In adult zebrafish tissues, Fmrp appeared to be primarily expressed in brain. Labelling 
was found in all differentiated neurons of the brain, including motorneurons, neurons of the 
telencephalon and Purkinje cells of the cerebellum. The Fmrp expression in brain is corresponding 
to the FMRP expression in human and mouse. In contrast, the extreme low Fmrp expression in 
immature spermatogenic cells in the testis of zebrafish and total lack of Fmrp in Western blot 
studies using testis homogenates from zebrafish differs from human and mouse. This suggests a 
less important Fmrp function within this tissue; however, we cannot exclude that testis specific 
isoforms from zebrafish are not well recognized by the zebrafish-specific antibodies used in our 
immunohistochemical experiments. 
In human and mouse brain four prominent isoforms are present with molecular weights 
ranging between 70 and 80 kDa 3,26. In Western blot analysis, antibody 758 revealed 2 bands in 
zebrafish brain; a prominent isoform of approximately 75 kDa and a much weaker isoform of 
approximately 70 kDa. This indicates alternative isoforms to be present in brain or a differential 
distribution of these two isoforms compared to the four isoforms present in human and mouse 
brain. Apparently the importance of specific isoforms, mediated by different splicing events, 
has changed during evolution. No specific role for individual isoforms has been identified.
The FMR1 gene, together with FXR1 and FXR2, forms a small gene family of highly homologous 
genes that can interact with each other. In mouse and man the three gene products, FMRP, 
FXR1P and FXR2P are closely related with respect to subcellular localisation and functional 
domains, however, FXR1P is highly expressed in striated muscle tissue whereas FMRP and 
FXR2P are absent in striated muscle tissue. In a recent study we have described the initial 
characterisation of Fxr1p in zebrafish (Engels et al., 2004). As Fmrp, Fxr1p was expressed in 
both the neurons of the brain and immature spermatogenic cells. In addition, Fxr1p expression 
was very high in striated muscle tissue from zebrafish, both in embryonic and adult stages, where 
it was localised in the costameric protein network. Apparently, Fxr1p has an unique function 
in myogenesis compared to the other two members of the small FXR family. This is further 
illustrated by the early demise of Fxr1 knockout mice (shortly after birth), as a consequence 
of striated muscle abnormalities, and the normal life expectancy of both the Fmr1 and Fxr2 
knockout mice (Mientjes et al., 2004).
In conclusion, the strong conservation of important functional domains and an almost similar 
localisation pattern of Fmrp (especially in brain) when compared with humans and mice makes the 
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zebrafish a suitable model for studying fmr1 protein function. Considering recent developments 
in manipulation of gene expression in zebrafish, such as (over)expression vectors using GFP-
fusion constructs and morpholino gene-targeting strategy to generate “knockdown” fish, opens 
new perspectives for understanding complex developmental neurogenetic disorders, including 
fragile X syndrome. Therefore, we propose the zebrafish as an attractive complementary 
vertebrate model to study fmr1 gene function during early embryonic development, especially 
in the brain. 
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Summary
The X-linked FMR1 gene, which is involved in the fragile X syndrome, forms a small gene family 
with its two autosomal homologs, FXR1 and FXR2. Mouse models for the FXR genes have been 
generated and proven to be valuable in elucidating the function of these genes, particularly in 
adult mice. Unfortunately, Fxr1 knock out mice die shortly after birth, necessitating an animal 
model that allows the study of the role of Fxr1p, the gene product of Fxr1, in early embryonic 
development. For gene function studies during early embryonic development the use of zebrafish 
as a model organism is highly advantageous. 
In this paper the suitability of the zebrafish as a model organism to study Fxr1p function during 
early development is explored. As a first step, we present here the initial characterisation of 
Fxr1p in zebrafish. Fxr1p is present in all the cells from zebrafish embryos from the 2/4 cell 
stage onward; however, during late development a more tissue-specific distribution is found 
with the highest expression in developing muscle. In adult zebrafish, Fxr1p is localised at the 
myoseptum and in costamere-like granules in skeletal muscle. In the testis, Fxr1p is localised 
in immature spermatogenic cells and in brain tissue Fxr1p displays a predominantly nuclear 
staining in neurons throughout the brain. Finally, the different tissue-specific isoforms of Fxr1p 
are characterised.
Since the functional domains and the expression pattern of Fxr1p in zebrafish is comparable to 
that in higher vertebrates such as mouse and human, we conclude that the zebrafish is a highly 
suitable model for functional studies of Fxr1p.
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Introduction
The small family of fragile X related (FXR) proteins consists of three proteins, including FXR1P, 
FXR2P and FMRP, the lack of which in neurons causes the fragile X syndrome 1,2. Both in 
human and mouse, the FXR-proteins are highly expressed in brain and testis, and, uniquely, 
FXR1P is expressed in striated muscle tissue, including both skeletal and heart muscle 3-8. The 
highly homologous FXR proteins share several functional domains among which two KH RNA 
binding domains and an RGG box, as well as nuclear localisation and export signal sequences 9-13. 
The association of both FMRP and FXR1P with mRNP particles present in actively translating 
ribosomes suggests that these proteins play a role in translational regulation 7,14-18. FMRP binds 
to target mRNAs with high affinity and this binding appears to be mediated by G-quartet 
structures in target transcripts, whereas for both FXR2P and FXR1P, target transcripts have not 
yet been identified 19-22. In vitro studies demonstrated the interaction of the three homologs with 
each other as homomers and heteromers 23. Recently, in vivo studies showed the presence of both 
FMRP and FXR1P in specific granules involved in dendritic mRNA transport using a stably 
transfected PC12 cell line (neuronal cell line) with an inducible expression system 24.
To study the physiological function of the three genes animal models have been created. The 
Fmr1 knock out mice display deficits in visual spatial performance and have macroorchidism, 
illustrating similarities between fragile X patients and this mouse model 25. In addition, Fmr1 
knockout mice show altered dendritic spine morphology, indicating a reduced maturation/
pruning of spines 26. Fxr2 knockout mice show a mild learning and behaviour phenotype 27. 
Thus, both mouse models point to a mental retardation phenotype in the absence of Fmrp and 
Fxr2p, respectively. In contrast, Fxr1 knockout mice die shortly after birth and show a disruption 
of the cellular architecture and structure of both skeletal and cardiac muscle tissue 8. The 
absence of Fxr1p in E19 Fxr1 knockout mice results in the reduced/abnormal expression pattern 
of costameric proteins like vinculin, dystrophin and α-actinin and it has been suggested that 
Fxr1p plays a role in transport/translational control of structural costameric mRNAs analogue 
to FMRP function for dendritic mRNAs 8. 
In order to further study the function of FXR1P in the nervous system, testis and striated 
muscle tissue, particularly during embryonic development, it may be advantageous to use a 
model organism that allows avenues to study early developmental processes in more detail. The 
zebrafish Danio rerio is very suitable in regard to developmental studies as it has a fast external 
development and developing zebrafish remain translucent until the embryos are free swimming 
and organogenesis is completed. Additionally the availability of techniques to manipulate gene 
expression, the vast knowledge base on zebrafish development and the near finished genome 
project make the zebrafish an attractive complementary vertebrate model. Importantly, orthologs 
of the three FXR genes have been identified in zebrafish 28.
In the present study an initial characterisation of Fxr1 in zebrafish has been conducted. We 
performed sequence analysis, embryonic and adult expression patterns using monospecific 
antibodies against Fxr1p, and Western blotting to detect the different molecular forms of 
Fxr1p.
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Materials	and	methods
Animals
Fish used in this study were from a locally kept line that derives from the Wageningen ZF WT 
Zodiac F5 line. Fishes were maintained at 25 °C in a 12 hr light/dark cycle and fed artemia 3 
times a day. 
Dissection of zebrafish
Male fish were euthanized in a 0.2 g/l solution of tricaine (3-amino-benzoic ethylester Sigma, 
St. Louis, USA) and brain, testis and a strip of dorsal skeletal muscle were dissected, snap frozen 
in liquid nitrogen and stored at -80°C till further use. 
Fxr-EGFP fusion expression constructs
For total RNA, tissues were removed from -80°C and immediately homogenized in 1.0 ml trizol. 
The homogenate was chloroform extracted and RNA was precipitated according to standard 
protocols. Subsequently, cDNA was prepared from 1 µg RNA using  AMV RT (Sigma) with 
random hexamers and oligo dT according the manufacturer’s instructions. 
Muscle and brain cDNA was amplified with Pfx DNA polymerase (Invitrogen, Carlsbad, USA) 
using the following Fxr1 primers: f1: 5’-CCGATCGCATGGAGGAACTGACGGTGG-3’ and 
r1: 5’-GTACTCCAGCAGCACCTGTACG-3’. The PCR product was cloned into pCRtopo 2.1 
TA (Invitrogen), and, in order to express Fxr1p as an enhanced green fluorescent protein (EGFP) 
fusionprotein, subcloned into pEGFP-C3 (Clontech, Palo Alto, USA) using the EcoR1 sites. Zebrafish 
Fxr2 cDNA was available as an image clone (genbank accession number: BC045999) which was 
ordered from MRC gene service and cloned into pCRtopo 2.1 TA by PCR using the primers: 
f3: 5’-AAGCGACGACGAACATGGAC-3’ and r4: 5’-ATGCAAGCAGGGACAGAGTT-3’, and 
subsequently subcloned into pEGFP-C3 (Clontech) using the EcoR1 sites. Both constructs were 
sequence verified.
Primary antibodies
Rabbit monospecific antibodies against Fxr1p were raised according to the double X program 
from Eurogentec (Herstal, Belgium). Briefly, synthetic peptides were produced from the C-
terminal sequence from zebrafish Fxr1p: AESQSRQTNPRDTRK that subsequently were 
coupled to KLH. The final bleeding was used to produce an affinity-purified antibody using 
affinity purification against the synthetic peptide. The affinity purified antibody (named affi 5) 
was used in a 1:500 dilution for immunoblotting and 1:25 dilution for immunohistochemistry. 
Antibodies against MANDRA1 (mouse anti-dystrophin; Sigma) and vinculin (goat anti-
vinculin; Santa Cruz) were used for immuno-histochemistry 1: 1000 and 1: 400, respectively. 
Antibodies against P0 and Staufen were from Immunovision (human; Bereldange, Luxembourg) 
and Chemicon (rabbit; Temecula, USA), respectively, and were used in a 1: 100 dilution for 
immunohistochemistry. The secondary antibodies swine anti-rabbit conjugated with HRP and 
rabbit anti-mouse conjugated with HRP were obtained from DAKO (Glostrup, Denmark). Goat 
anti-rabbit/mouse/human conjugated with TRITC or FITC was obtained from Sigma.
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Cryosectioning and immunohistochemistry
Adult zebrafish were euthanized (see above) and embedded in Tissue-Tek (Sakura Finetek 
Europe B.V.). Using a Leica Jung CM3000 cryostat, 7µm sections were cut and thaw-mounted on 
microscopic slides. Sections were fixed at room temperature for 10 min in 4% paraformaldehyde 
in 0.1 M Sorrensen buffer, pH 7.3 followed by a permeabilisation step in 100% methanol for 20 
min. Sections were rinsed twice in PBS for 5 min and subsequent endogenous peroxidase activity 
was blocked for those slides that were incubated using the immunoperoxidase protocol using 
hydrogen peroxide (0.6%). After blocking, slides were washed twice in PBS+ (PBS containing 
5 g non fat dry milk and 1.5 g glycine/L) for 5 min. Incubation with primary antibodies was 1.5 
hr at room temperature or overnight at 4°C. Slides were rinsed three times in PBS+ for 5 min 
and incubated with secondary antibodies (both conjugated with FITC/TRITC or HRP) for 1 hr 
at room temperature. After three washes with PBS+, slides were either covered with a coverslip 
using Vectashield containing Dapi (Vector Laboratories, Burlingame, USA) or further incubated 
with DAB-substrate (DAKO) for 6 min, followed by washing in tap water. Finally, sections were 
counterstained using haematoxylin and embedded in Entellan (Merck, Darmstadt, Germany). 
Slides were examined with either a fluorescence microscope or a bright field microscope.
Cell lines and transfection studies
Cos-1 cells were maintained in DMEM (Gibco Brl, Breda, The Netherlands) supplemented with 
10% FCS (Gibco Brl) under 5% CO
2
 at 37 °C. Cells were seeded on coverslips or in 6 wells 
plates at 75% confluence the night before transfection. Transient transfection was performed 
using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. Cells were 
lysed the following day in Ripa (20 mM Tris pH7.5, 140 mM NaCl, 0.1% deoxycholate, 0.1% 
sodium dodecylsulphate, 0.5% Triton) and complete protease inhibitor cocktail (Roche, Basel, 
Switzerland) or, for immunocytochemistry, fixed in 4% paraformaldehyde in PBS for 10 min 
and permeabilized in 100% methanol for 20 min. For immunofluorescence the same protocol 
was followed as for the immunohistochemistry.
Western blotting
Zebrafish tissues were homogenized in Ripa, centrifuged at 12000 g for 15 min at 4°C and 
supernatants were stored at -80°C till further use. Homogenates from zebrafish brain, testis, 
muscle and Cos-1 cells transfected with the FXR1-pEGFP or FXR2-pEGFP constructs were size 
separated on 7.5% SDS-PAGE and immunoblotted according to standard protocols. 
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AVKQARTYLEFKEDSFPVPRNLVGKVIGKNGKIIQEIVDKSGVVRVRIEGDNDK-KLPREEGGRQGAGRDNIVSSQEGTVPFIFVGTKEN
AVRKARSYLEFSEDVIKVPRNLVGKVIGKSGKLIQEVVDKSGVVRVRVEPENDKKPSPLEE----------------GMVPFVFVGTKES
: 343
: 343
: 343
: 359
: 344
Hs_FXR1P :
Mm_Fxr1p :
Dr_Fxr1p :
Dr_Fxr2p :
Dr_Fmrp :
IGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGS--RSYSGR----------------------------------GRGRRGPNYTS
IGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGMGFRPSSTR----------------------------------GPEREKGYATD
ISNVQVLLEYHIAYLNEVEQLRLERLQIDEQLRQIGMGFRSVPNRPADKEKGF---------GPDESSSGSIHTQRSYRGRGRRGPAHTS
ISNAQALLEYHVAYLQEVEQLRLERLQIDEQLRQIGVGYRAPPSRSGSGVAGERERGYLTDESTN-SLQTTRTYGG--RGRGRKPNNTYS
ISNARILLDYHLNYLKEVDQLRMERLQIDEQLRQIGGGPRALPGRPEKEKS----------FMADNGMGPSRGGGKPFGRGGRGRRGPTL
: 397
: 399
: 424
: 446
: 424
Hs_FXR1P :
Mm_Fxr1p :
Dr_Fxr1p :
Dr_Fxr2p :
Dr_Fmrp :
GYGTNSELSNPSETESERKDELSDWS-LAGEDNRDSRHQRDSRRR-PGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNPYSLLDNTES
ESTVSSVQGSRSYSGRGRGRRGPNYTSGYGEDDRETRHQRDSRRR-PGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNPYSLLDNTES
AYGTNSEHSYTSETDSERKAELSDWSLAADESERNPRPQRDSRRRDMRGRGR---GSRGRGS--GASNSISSVLKDPDGNPYSLLDNTET
GYGTNSEMSNASETEDLGDRE--SRPKGVGADDRGSK-RGGRGRGSSAGRGR-GGP-GPR-----NINTISSVLRDPDSNPYSLLE-GEG
ASGTNSEASNASETESDHRDELSDWSLAPTDEESMGYPKRAPDGRKRGGGPR---GRGGRG----- ---RG
: 485
: 488
: 509
: 525
: 484
Hs_FXR1P :
Mm_Fxr1p :
Dr_Fxr1p :
Dr_Fxr2p :
Dr_Fmrp :
DQTADTDASESHHSTNRRRRSRRRRTDEDAVLMDGMT-ESDTASVN-ENGL- VTVAD
DQTADTDASESHHSTNRRRRSRRRRTDEDAVLMDGLT-ESDTASVN-ENGLDDSEKKPQRRNRSRRRRFRG-------QAEDRQPVTVAD
DQTADTDGSESQMNTSRRRRSRRRRTDEDTTVMDGMS-ESDNASLS-ENGLDEAEAKSQRRNRSRRRRFR--------PPEERQPVTVAD
EQGGDTDASESMGGIDRRRRSRRRRNDLEPSLMDAAANESDGQGATSENGLEE-EGRPQRRNRSRRRRNRANRPEGGSTSRDRQPVTVAD
G-YK-TEDMHWNDSRSRSSRDSKLRPQEESR---------------------------------------- QIRIDS
: 539
: 569
: 589
: 614
: 519
Hs_FXR1P :
Mm_Fxr1p :
Dr_Fxr1p :
Dr_Fxr2p :
Dr_Fmrp :
YISRAESQSRQRNLPRETLAKNKKEMAKDVIEEHGPSEKAINGPTSASGDDISKLQRTPGEEKINTLKEENTQEAAVLNGVS
YISRAESQSRQRNLPRETLAKNKKEMAKDVIEEHGPSEKAINGPTSASGDEIPKLPRTLGEEKTKTLKEDSTQEAAVLNGVS
YISRAESQSRQTN-PRDTRKSKKDMTRGDFISEHSAAESVSNGPNNAD--------------------EPSESAKAVVNGVS
FISRAESQSRQNLPGKEANP-HASHPKENGTSVSKEERTPSKRSPSNGVA-------------------SPGEALAMVNGVS
NNERSIHTSRSSQAMAGARGGNRQRPIKERVMKKEKQD-------------------------------GSD-SQAVVNGVS
: 621
: 651
: 650
: 676
: 569
KH1
KH1
CKII
NoS1 NoS2
Epitope Affi5:
AESQSRQTNPRDTRK
NES
NLS
RGG
Figure	1.	Comparison	of	human	FXR1P	and	the	zebrafish	Fxr-protein	family.
Identical residues are shaded in black, and conserved substitutions in grey. The following functional domains are 
indicated: the nuclear localisation signal (NLS), the two KH1 RNA-binding domains (KH1), the nuclear export signal 
(NES), the conserved casein kinase II phosphorylation site found in drosophila Fmrp (CKII), the region containing the 
RNA interaction RGG box (RGG) and two nucleolar targeting signals (NoS1 and NoS2). The boxed region of mouse 
and zebrafish Fxr1p that contains the second NoS indicates the alternatively spliced exon 15 of Fxr1p. The epitope of 
the affinity-purified anti-Fxr1p antibody Affi5 is depicted with the synthetic peptide.
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Results
Zebrafish Fxr genes are highly homologous 
Zebrafish FXR cDNAs have been cloned 28,29 and sequences are available in the public domain 
(NCBI accession: NM_152963 for fmr1, BC055557 for fxr1 and BC045999 for fxr2). As shown 
in the protein alignment (Figure 1), these sequences display a high degree of homology, 
encompassing all known functional domains. Strikingly, we were unable to identify CGG 
repeats within the zebrafish Fmr1 5’ untranslated region (5’UTR).
Cloning of zebrafish Fxr1
The PCR fragment cloned from zebrafish muscle cDNA spans the open reading frame and is 
identical to the published gene bank sequence, except that it also contains exon 15 (numbering 
according 30, Figure 1, boxed region). 
Specificity of affinity purified polyclonal antibody against zebrafish Fxr1p
According to the protein alignment in Figure 1 the zebrafish Fxr proteins are highly homologous 
and the predicted molecular mass of both Fxr1p and Fxr2p are approximately identical. The 
Affi5 antibody was raised against the zebrafish Fxr1p using a synthetic peptide; however, 
part of the used peptide is also present in zebrafish Fxr2p. Therefore we examined whether 
Affi5 cross reacts with zebrafish Fxr2p. In order to determine the specificity of Affi5 we 
transiently overexpressed zebrafish Fxr1-EGFP and Fxr2-EGFP in Cos-1 cells and performed 
immunofluorescence using Affi5 antibody. In addition, cell homogenates were prepared for 
Western blotting. For immunofluorescence, Affi5 showed a strong labelling of Cos-1 cells 
expressing Fxr1p-EGFP (Figure 2A for GFP staining and 2B for Affi5 staining), whereas Cos-1 
cells overexpressing Fxr2p-EGFP showed total absence of labelling for Affi5 (Figure 2D) while 
an intense staining could be detected for GFP fluorescence signal (Figure 2C).
In immunoblotting, Affi5 recognizes the Fxr1p-EGFP fusion protein. The size of the band is 
approximately 100 kDa, which reflects a molecular mass of 73 kDa for Fxr1p, and 27 kDa 
for EGFP. In contrast, Affi5 staining did not detect the Fxr2p-EGFP fusion protein (panel F, 
compare lanes1 and 2). Note that equal amounts of Fxr1-EGFP and Fxr2-EGFP fusion protein 
were present as shown by immunoblotting using antibodies against GFP (panel E, lanes 1 
and 2).
Distribution of Fxr1p in adult zebrafish 
In man and in mouse Fxr1p is highly expressed in skeletal muscle, heart, testis and brain. As an 
indication whether Fxr1p has a role in zebrafish comparable to that in mouse or in human, and 
whether it would therefore be a suitable model to study the function of Fxr1p, we examined the 
distribution of Fxr1p in the zebrafish using Affi5 antibodies using cryostat sections from adult 
zebrafish.
Immunoreactivity of Affi5 was observed in the brain, most notably in the Purkinje cells of the 
cerebellum and a number of neurons in the brainstem. Surprisingly, a significant number of 
neurons throughout the brain display nuclear staining (Figure 3A). 
Although Fxr1p is highly expressed in the testis, the signal is restricted to the immature 
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spermatogenic cells (Figure 3B). Skeletal muscle showed the highest level of Fxr1p expression, 
where it was localised in granular structures throughout the muscle fiber and intensely at the 
sarcolemma. Furthermore, a very intense and granular staining was observed bordering the 
myoseptum (Figures 3C and 3D). The signal of Fxr1p at the myoseptum extends somewhat into 
the cytoplasm, more so than at the sarcolemma.
Figure	 2.	 Specificity	 of	 affinity-
purified	antibody	Affi5.	
Cos-1 cells were transiently transfected 
with EGFP-Fxr1 (A and B) or with EGFP-
Fxr2 (C and D), and stained with Affi5. 
The EGFP signal (A and C, green) is 
present in both transfected Cos-1 cells, 
while Affi5 labelling is only present in 
EGFP-Fxr1 transfected Cos-1 cells (B, 
red). Cos-1 cells transfected with EGFP-
Fxr2 show absence of labelling after Affi5 
incubation (D).
Lysates of EGFP-Fxr1 (lanes 1) and EGFP-
Fxr2 (lanes 2) transfected Cos-1 cells 
were immunoblotted using antibodies 
against EGFP (E, lanes 1 and 2) and Affi5 
(F, lanes 1 and 2). Note the absence of 
cross reactive material in the lane with 
EGFP-Fxr2 transfected Cos-1 cells using 
Affi5 antibodies (F, lane 2). Bars 10µm
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Fxr1p in the developing zebrafish 
To study the expression of Fxr1p during embryonic development and to test whether it was 
localised in a similar pattern as in adult tissues, zebrafish embryos at different stages were 
embedded in tissue tek and cryosections were immunoincubated with Affi5. 
Fxr1p can already be detected in the 2/4 cell stage where it is distributed evenly over the cell 
mass (data not shown). At the dome /epiboly stage at 6 hpf (hours post fertilisation), Fxr1p 
was present at high levels in all the cells (Figure 4A). From early somitogenesis onward Fxr1p 
is expressed at very high levels in myoblasts throughout the somites. During the maturation 
of the embryos (1dpf - 5 dpf) the immunoreactivity gradually concentrates at the myosepta 
and at the sarcolemma in regularly placed granular structures. Figure 4B illustrates the weak 
Fxr1p expression in the head of an embryo 1 dpf, whereas the tail from 1 dpf embryos showed 
a high Fxr1p expression in myoblasts (Figure 4C). In embryos at 3 dpf Fxr1p expression level is 
moderate in the brain and very high in myoblasts (Figures 4D and 4E, respectively). 
Fxr1p isoforms are differentially expressed in zebrafish tissues.
In the mouse, a number of different isoforms of Fxr1p has been described, due to extensive 
alternative splicing. We examined the presence of different isoforms of Fxr1p in zebrafish by 
Figure	3.	Immunohistochemical	analysis	of	Fxr1p	expression	in	adult	zebrafish	tissues.
Cryostat sections from adult zebrafish were immuno-incubated using Affi5 antibodies. In the brain, the testis and 
in skeletal muscle tissue significant Fxr1p expression was present. Note the nuclear labelling in Purkinje cells of the 
cerebellum (A; bar 3.5 µm). All immature spermatogenic cells of the testis showed Fxr1p expression (B; bar 30 µm). 
A transversal section of skeletal muscle shows that Fxr1p expression is mainly present at the sarcolemma and at the 
myoseptum (C; bar 80 µm). A higher magnification of the myoseptum is shown in D( bar 320 µm). The Purkinje cells, 
immature spermatogenic cells, the sarcolemma and the myoseptum are denoted by P, I, S and M, respectively.
Characterisation of Fxr1 in Danio rerio 3
Figure	4. Immunohistochemical analysis of Fxr1p expression in zebrafish embryos during embryonic development
Longitudinal cryostat sections of 6 hpf embryos (A; bar 70 µm)), 1 day old embryos (B; head and C; tail; bars 30 and 15 
µm, respectively) and 3 dpf embryos (D; head and E; tail; bars 100 and 35 µm, respectively) were stained for zebrafish 
Fxr1p using Affi5. The inset in D shows a higher magnification of the boxed region in the hindbrain from D. Note 
the nuclear staining in neurons from 3 dpf embryos (D) and the very intense staining of myoblasts in muscle tissue 
within the somites (E). The yolk sac visible in panel A is denoted by Y, the myoseptum and the neural tube in panel 
E are indicated with M and N respectively. Arrows in C point to Fxr1p immunoreactive myoblasts in the developing 
somite.
Western blot analysis using different tissues, including brain, skeletal muscle and testis. In 
brain, the most prominent isoform is approximately 74 kDa (Figure 5, lane 1). In muscle tissue 
we could detect Fxr1p isoforms (two major bands) of approximately 80 - 88 kDa (Figure 5, lane, 
2) and in testis the most prominent isoform was 72 kDa (Figure 5, lane 3). 
Figure	 5.	Analysis	 of	 Fxr1p	 isoforms	 in	
adult	zebrafish	tissues
Homogenates of adult zebrafish brain, 
muscle and testis were immunoblotted 
using Affi5 antibodies to detect the presence 
of molecular forms from Fxr1p. In brain a 
prominent band of approximately 73 kDa 
and a low-intensity band of approximately 
70 kDa are present. In skeletal muscle high 
molecular weight isoforms of Fxr1p are 
present of approximately 86-88 kDa. The 
detection of Fxr1p isoforms in testis results 
in a prominent band of 73 kDa and weaker 
bands of 77 kDa and 88 kDa.
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Colocalisation of Fxr1p with components of the translational machinery
In mammals, Fxr1p is incorporated in mRNP particles within actively translating ribosomes 7,31-33. 
Furthermore, it has been described that (poly)ribosomes are located at the myoseptum, and 
that transcripts can be translated locally 34,35. We therefore set out to determine whether P0, a 
protein component of ribosomes, and Staufen, which can form complexes with both FMRP and 
FXR1P and is known to be involved in transport/translation of mRNAs, are also localised at 
the myoseptum. 
To this end, cryosections of adult zebrafish were immunoincubated simultaneously with Affi5 
in combination with anti-Staufen or with anti-P0 antibodies. Both the Staufen antibody and the 
P0 antibody recognized the zebrafish orthologs and showed a strong immunoreactivity at the 
myoseptum and at the sarcolemma. Staufen immunoreactivity appears to be more concentrated 
around junctions of fibers (Figure 6A), whereas P0 appears to be relatively more localised at the 
myoseptum (Figure 6E). Simultaneous distribution with Fxr1p (Figure 6B and 6D) illustrates the 
co localisation with Staufen to some extent (Figure 6C, merge) and with P0 in higher quantities 
(Figure 6F, merge).
Figure	6.	Colocalisation	of	Fxr1p	with	components	of	the	translational	machinery
Transverse cryostat sections of skeletal muscle tissue from adult zebrafish were stained for Fxr1p (B, red and D, 
green), Staufen (A, green) and P0 (E, red). Figures C and F depict the merge images of A,B and D,E, respectively. 
Colocalisation is shown by yellow staining. The myoseptum and the sarcolemma are denoted by M and S, respectively. 
Bars 40 µm
Fxr1p is localised next to dystrophin and vinculin at the myoseptum
The localisation of Fxr1p at the myoseptum is reminiscent of that of dystrophin in zebrafish. 
Additionally, Fxr1p has been reported to be localised in costameres 7. Next we would like to 
study whether Fxr1p is colocalised with vinculin and dystrophin, two proteins of the costameric 
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protein network, and to explore a potential role of Fxr1p in the maintenance of the structural 
integrity of costamers. We therefore examined the localisation of Fxr1p in relation to dystrophin 
by double immunofluorescence in combination with confocal microscopy using cryosections 
from muscle tissue. 
Frx1p, vinculin and dystrophin are all three localised at the myoseptum. However, this close 
localisation at the myoseptum of Fxr1p on the one hand and vinculin and dystrophin on the 
other hand is not a exact co localisation as shown in Figure 7 using confocal analysis. Closer 
examination reveals that the signals only partly overlap. Both vinculin and dystrophin are 
localised more to the centre of the myoseptum than is Fxr1p.
Figure	7.	Fxr1p	is	localised	next	to	vinculin	and	dystrophin
Longitudinal cryosections of skeletal muscle tissue from adult zebrafish were stained for Fxr1p (A and D, green), 
vinculin (B, red) and dystrophin (E, red) and examined using confocal microscopy. Images were taken in one confocal 
plane. Figures C (bar 5 µm) and F (bar 50 µm) show overlays of Fxr1p with vinculin and dystrophin, respectively. Note 
that only partial overlap is observed. Myosepta are indicated by M.
Discussion
In the present study we performed an initial characterisation of Fxr1 expression in zebrafish. 
In vitro studies in both human cells and mouse models have revealed important data about 
the physiological function of Fxr1p. Nevertheless, the precise cellular function of Fxr1p 
remains unknown. The main reason for this is that Fxr1 knock-out mice die shortly after birth, 
suggesting an important cellular function of Fxr1p during embryonic development or neonatally. 
Unfortunately, the mouse is not an ideal model to study gene function during early embryonic 
development. Thus, knowledge about Fxr1p function during (early) embryonic development 
is essential to gather knowledge about Fxr1p function and to understand the demise of the 
neonatal knockout mice. The zebrafish is a widely used developmental model organism that 
combines the attractive features of the invertebrate models on the one hand and the higher 
model systems such as mouse, on the other hand 36,37. The diploid zebrafish embryos, like those 
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of the invertebrates have a fast external development and are produced in high numbers per 
breeding. These characteristics make large scale forward genetics approaches very effective. 
In addition, the zebrafish has basically the same anatomical organisation as man, and data on 
gene function obtained from zebrafish are highly applicable in the context of human diseases 
and development 38,39.
To examine the feasibility of the zebrafish as a model for Fxr1p function we first compared the 
zebrafish Fxr1p sequence with that from human and mouse. Fxr1p is highly conserved between 
these different species and all major domains that have been described to play a role in the 
function of the FXR family of proteins are present in zebrafish Fxr1p, although the alignment for 
the RGG-box domain in zebrafish Fxr1p was not unambiguously clear (figure 1). Nevertheless, 
the evolutionarily conserved domains in zebrafish Fxr1p suggest that Fxr1p has a cellular 
function in zebrafish similar to that in human and mouse.
Next we examined the expression pattern of Fxr1p in zebrafish to establish whether it is 
expressed, as in mammals, predominantly in skeletal muscle, testis and brain. In embryos, Fxr1p 
is ubiquitously expressed in all cells between 0 hpf and 6 hpf. From 1 dpf onward, Fxr1p showed 
a more tissue-specific expression with a very high expression in myoblasts and a moderate 
expression level in neurons from the central nervous system. This more differential expression 
was also observed during late embryonic development in the mouse 6. In 3 dpf embryos, Fxr1p 
was present in almost all the neurons of the central nervous system with a high expression in the 
Purkinje cells of the cerebellum, but, surprisingly, a significant number of neurons displayed a 
predominantly nuclear staining. Interestingly, a nuclear staining of neurons has been reported 
for FXR1P in human fetal brain (18 weeks) as well 4. 
The labelling intensity of Fxr1p in skeletal muscle tissue from both 1 and 3 dpf embryos was 
very high compared to the brain tissue and suggests an important role for Fxr1p in myogenesis. 
At this stage of development Fxr1p already showed the characteristic costamere localisation. In 
the adult zebrafish, Fxr1p expression was tissue specific and similar to the differential expression 
in man and mouse, that is, high expression in brain, striated muscle tissue and testis. However, 
the subcellular distribution of Fxr1p in neurons from adult zebrafish was predominantly nuclear 
as observed in 3dpf embryos as well. This is in contrast with the human and mouse subcellular 
Fxr1p localisation in neurons, which is predominantly cytoplasmic 5,31. 
The difference in subcellular localisation of Fxr1p indicates that the cellular context of adult 
zebrafish neurons may share characteristics with that of human fetal neurons (Tamanini et al., 
1997). 
The subcellular localisation of Fxr1p in striated muscle tissue was in granular structures at the 
sarcolemma, which appear to be costameres as the granular Fxr1p staining overlaps with that 
of vinculin and dystrophin, both are components of the costameric protein network 40. This 
is in agreement with previous reports in mice that also described Fxr1p staining in granular 
structures in costameres 7,8. Most striking is the predominant localisation of Fxr1p at the 
myosepta. These structures have been linked to laminar tendons and serve to transmit the force 
of the contracting muscle segments to the vertebral column 41,42. This localisation of Fxr1p is, 
however, not entirely surprising as Fxr1p is probably, like FMR1P, involved in transport and/or 
regulation of translation of specific mRNAs. It has been described that both at the myoseptum 
and next to the costameres large numbers of actively transcribing (poly)ribosomes are located 43. 
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Considering these findings it is tempting to hypothesize that Fxr1p is involved in local translation 
of transcripts encoding proteins that are of importance for these structures. Further exploring 
this notion, we determined the localisation of Staufen and P0 in double labelling experiments. 
Indeed, both proteins showed a co localisation with Fxr1p, albeit with different intensities. The 
presence of P0, a component of the 60S ribosomal precursor unit, illustrates the presence of 
ribosomes at the myoseptum and at the sarcolemma in zebrafish skeletal muscle. Thus, Fxr1p 
might be associated to (poly)ribosomes in zebrafish muscle, which is in line with a role for Fxr1p 
in transport and/or translation of specific mRNAs in the vicinity of costameres 43.
Staufen has been reported to be present in RNP particles that also contain FMR1 and FXR1p 44. 
Recent data show that Staufen protein is localised at the neuromuscular junctions (NMJ) and 
may be involved in maturation and plasticity of the NMJ 45. Although Staufen is, like Fxr1p, 
present both at the sarcolemma and at the myoseptum in zebrafish muscle, it has a distinctly 
different pattern of signal intensity, being more concentrated around junctions of fibers with the 
myoseptum and other musclefibers. These concentrations of Staufen immunoreactivity could 
correspond to the NMJs. This suggests that, although Fxr1p and Staufen can be both present in 
RNP particles in the brain and may partially colocalise in zebrafish muscle, both proteins have 
distinct roles in zebrafish skeletal muscle tissue.
The localisation of Fxr1p at the myoseptum is reminiscent of the localisation of dystrophin and 
vinculin in zebrafish. Both proteins are components of the myoseptum and provide a connection 
between the extra cellular matrix (ECM) and the intracellular cytoskeleton 40,46,47.  
Hypothetically, Fxr1p could be involved in maintaining muscle fiber integrity by a direct binding 
to components of the myoseptum, such as dystrophin or vinculin. We therefore examined the 
possible colocalisation of dystrophin and vinculin protein using confocal immunofluorescent 
imaging. As both vinculin and dystrophin are distinctly more centrally localised at the 
myoseptum than Fxr1p, it is unlikely that Fxr1p is part of the dystrophin-containing complex that 
anchors the muscle fiber to the ECM. However, dystrophin mRNA shows a distinct localisation 
bordering at the myoseptum from 19 hpf onward and appears to be located immediately outside 
the myoseptum itself, where dystrophin protein is located 46. Comparing these findings to our 
confocal study on the possible colocalisation of Fxr1p with dystrophin or vinculin, it appears 
likely that Fxr1p may colocalise with dystrophin mRNA. Further in situ hybridisation studies 
are necessary to establish this colocalisation.
The Fxr1p localisation in zebrafish testis appears to be predominantly in all the immature 
spermatogenic cells, which has also been observed in mouse and human, albeit Fxr1p 
immunoreactivity has also been reported in the tails of murine sperm using antibodies against 
high molecular isoforms of Fxr1p 4,16. 
In conclusion, the functional domains of Fxr1p are evolutionary conserved in zebrafish and the 
expression pattern of zebrafish Fxr1p is consistent with the expression of the Fxr1p orthologs in 
mouse and man. Thus, zebrafish should be an outstanding model organism to study the cellular 
function of Fxr1p, particularly during embryonic development and neonatally. Especially, 
gene knockdown experiments using the morpholino gene-targeting strategy and transgenic 
techniques using expression plasmids with Fxr1-EGFP may open new avenues that will lead to 
knowledge about the in vivo function of Fxr1p.
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Abstract
The FXR gene family consists of three members; FMR1, FXR1 and FXR2. Lack of the FMR1 
gene product (FMRP) results in the fragile X syndrome, whereas for the other two genes no 
human disease has been identified yet. Although mouse models have been generated for all 
three FXR genes our knowledge about the in vivo gene function during embryonic development 
is limited. Interestingly, the Fxr1 knockout mice display a striated muscle phenotype and die 
shortly after birth. We applied the zebrafish as a new genetic model system to study FXR gene 
function during embryonic development. Here we report antisense morpholino knockdown 
studies to study the function of Fxr1p during embryonic development. The fxr1 morphants 
display a striated muscle phenotype and severe heart malformations. Initial characterisation of 
Fxr1p in zebrafish shows an abnormal somite formation and, in contrast to other Fxr1p animal 
models, a failure in looping of the heart.
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Introduction
The FXR protein family of RNA binding proteins consists of three members; FMRP, FXR1P and 
FXR2P. The FMR1 gene product, FMRP, has been extensively studied due to its involvement in 
the fragile X syndrome, which is mainly characterised by mental retardation, macroorchidism 
and mild facial dysmorphologies. The gene affected in this syndrome, FMR1, is transcriptionally 
silenced by the methylation of its promoter due to the expansion of a CGG repeat in the 5’ UTR 
of the gene. Thus the fragile X syndrome is caused by the absence of FMRP. For FXR1P and 
FXR2P no human disease has been described so far.
The FXR proteins have RNA-binding capacities via two KH domains and one RGG box. Further 
they exhibit a nuclear export signal (NES) and a nuclear localisation signal (NLS), which allow 
the protein to shuttle between the nucleus and cytoplasm. All three FXR proteins show a high 
expression in the brain and testis. In addition, FXR1P is also highly expressed in striated 
muscle tissue and was found to localise along the Z-lines and costameres 1-6. Furthermore, all 
FXR proteins are found to be associated with ribosomes in the form of messenger ribonuclear 
particles (mRNP) 1,7. Both the high conservation among the FXR proteins and the overlap in 
tissue distribution, suggest that FXR1P and FXR2P might have a similar function as FMRP 
in the regulation of transport and/or translation of specific mRNAs. The overlap in cellular 
function between the three members and the exaggerated phenotypes observed in Fmr1/Fxr2 
double knockout mice support a mechanism in which Fmrp and Fxr2p modulate each others 
function 8. Since FXR1P is the only family member expressed at high level in striated muscle 
tissue the other two members are not able to compensate for the lack of FXR1P in this tissue. 
To study the in vivo function of FXR1P, animal models are crucial. The high evolutionary 
conservation between the different species of the FXR1 gene enables such studies. As a first step, 
Fxr1 knockout mice have been generated 6. These mice died shortly after birth and appeared to 
suffer from a striated muscle phenotype. They display a disruption of the cellular architecture of 
striated muscle tissue. Due to the absence of Fxr1p in costameric regions of striated muscle tissue, 
the costameric proteins vinculin, dystrophin and alpha-actinin are delocalised 6. Recently, Fxr1 
knockdown experiments in Xenopus laevis have been reported. Fxr1 knockdown in Xenopus 
showed a muscle-specific phenotype, including abnormal formation of the somites suggesting 
that Fxr1p is required during the formation of functional muscle 9. The early lethality of Fxr1 
KO neonates prompted us to study Fxr1p function during embryonic development in a more 
suitable animal model; the zebrafish (Danio rerio).
Zebrafish muscle development starts early during somitogenesis with adaxial cells that express 
myogenic factors, like MyoD. These adaxial cells lie adjacent to the notochord, migrate laterally 
of the somite and elongate into mononucleated slow muscle fibres [Devoto, 1996 #141]. The slow 
muscle fibres act as a template for the differentiation of fast muscle fibres, which develop from 
the remainder of the presomitic cells [Devoto, 1996 #141; Stickney, 2000 #12; Wolff, 2003 #149; 
Blagden, 1997 #145; Henry, 2004 #150]. 
We have previously shown that the functional domains of FXR genes are conserved in zebrafish 
and that the expression pattern of Fxr1p in zebrafish is similar to human and mouse 10. In adult 
zebrafish, Fxr1p is localised at the myosept and in costamere-like structures in striated muscle 
tissue. In addition, Fxr1p is present in immature spermatogenic cells and in brain tissue. In situ 
hydridisation studies has shown that fxr1 mRNA expression in zebrafish is high in the anterior 
of the embryo, and fxr1 is raised in adaxial and somitic cells from 12 till 24 hpf 11.
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We performed fxr1 knockdown experiments using morpholino technology to study the role 
of Fxr1p, especially during early embryonic development. The fxr1 morphant showed a 
disorganisation of the striated muscle and a severe heart phenotype. The heart failed to loop and 
became string-like when higher concentrations of fxr1 morpholino are injected. In addition, an 
abnormal somite formation was observed with a disruption of the MyoD pattern, suggesting an 
aberrant migration of the adaxial cells.
Material	&	methods
Zebrafish strains and care
The zebrafish (Danio rerio) strain used for this work was obtained from Wageningen ZF WT 
Zodiac F5 line. Fish were maintained at 25 °C on a 14 h light/10 h dark cycle. 
Embryos were raised at 28.5 °C and different developmental stages were determined 
according to 12.
Morpholino injection
Morpholino antisense oligonucleotides targeting the ATG (MO-ATG), the 5’UTR (MO-UTR) 
and the mismatch morpholino (MOmm), containing 7 mismatches, were purchased from Gene 
Tools. Sequences were as follows: MO-ATG 5’-gtcagttcctccatgttgagcgcga-3’, MO-UTR 5’-
gatgctgggtaaagttccagaac-3’ and MOmm 5’-gcctttgcgtttccaacatggagga-3’. Morpholinos were 
dissolved to a stock concentration in distilled water and further diluted in 1x Danieau solution (58 
mM NaCl, 0.7 mM KCl, 0.4 mM MgSO
4
, 0.6 mM Ca (NO
3
)
2
, 5 mM Hepes, pH 7.6) and a 0,05% 
solution of Phenol Red (Sigma). Zebrafish embryos were injected into the yolk at one to four cell 
stages using a pneumatic picopump (World Precision Instruments). Different concentrations 
of fxr1 MO were injected to determine the optimum concentration of fxr1 MOs (1-15 ng). As 
the observed phenotype was dosage-dependent, most of the experiments were carried out with 
embryos injected with 4 and 8 ng of fxr1 MO.
Western blot analysis
MO (8 ng) injected and WT zebrafish embryos were analysed at 1, 2 and 3 dpf. Western 
blot analysis was carried out as previously described 13. For immunodetection a zebrafish 
specific antibody against Fxr1p (affi5) was used in a concentration of 1: 500 10. The secondary 
antibody (goat anti-rabbit Igs; 1:5000) conjugated with peroxidase allowed detection with the 
chemiluminescence method (ECL Kit, Amersham). As a control for equal amounts per lane, the 
same samples were stained for actin (AC-40 from Sigma, 1:1000). 
Histology, immunocytochemistry and in situ hybridisation
Routine histology and immunohistochemistry were performed as previously described 13. The 
primary antibodies used to stain were actin (AC-40 from Sigma), dystrophin (Mandra1 from 
Sigma) and vinculin (Santa Cruz). For all stainings, an anti-mouse or anti-goat Igs conjugated 
with peroxidase as secondary antibody (1: 100) was used.
Whole mount in situ hybridisation was performed with digoxigenin (DIG) labeled RNA probes. 
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The probes MyoD and Cmlc were kindly provided by the Hubrecht Laboratory 14,15. In situ 
hybridisation was performed as described 16.
Results
Characterisation of the fxr1 morphant phenotype
The role of Fxr1p during early zebrafish development was studied using two different morpholinos 
(MOs). The MOs were designed against the start site (MO-ATG) and against the 5′ untranslated 
regions (MO-UTR) of the zebrafish fxr1 cDNA, and both gave a similar phenotype when injected 
into the yolk of a 1-4 cell stage. Also further characterisation of the fxr1 morphants, using 
histology, in situ hybridisation and immunocytochemistry, showed a similar result between the 
two MOs. Embryos injected with MO-ATG and MO-UTR displayed both a curled and/or reduced 
tail and cardiac abnormalities, whereas embryos injected with MOmm showed no apparent 
phenotype (data not shown). The fxr1 morphant phenotype showed a dosage-dependent effect, 
as the severity of the phenotype increased with higher MO concentrations, which is illustrated 
in figures 1A-1C for MO-ATG. In embryos injected with 4 ng MO the characteristic phenotype 
became clearly recognizable at 24 hpf (Figure 1B) and more pronounced with 8 ng MO (Figure 
1C).  The reduction of the tail was already clearly visible at 24 hpf and varied from a curly tail, 
reduction of the tail to complete absence of the tail (Figures 1B and 1C). All fxr1 morphants 
showed at 24 hpf U-shaped somites (Figure 1E for 8 ng MO-ATG), compared to the V-shaped 
myotomes in WT embryos (Figure 1D). In addition, the horizontal myosept was lacking. All 
morphants displayed a poor motility (data not shown). The cardiac defects observed in fxr1 
morphants include the absence of looping and pericardial oedema. When lower concentrations 
of MOs (4 ng) were injected, both the ventricle and atrium could still be identified in the linear 
heart, however, both were dilated (Figure 1G), while at higher concentrations (8 ng) only a linear 
heart tube without dilatations could be observed (Figure 1H). At 3 dpf, the rate of the heartbeat 
of embryos injected with 4 ng or 8 ng was significantly reduced to 155 and 66 beats/minute, 
respectively (normal ~190 beats/ minute). In general, embryos injected with either 4 ng or 8 ng 
of MOs causes a severe phenotype and is embryonically lethal at 4 dpf and 6 dpf, respectively. 
Reduced levels of Fxr1p
The effectiveness of the MOs was determined by quantitative Western blot analyses using 
monospecific antibodies raised against zebrafish Fxr1p. For this experiment either MO-ATG or 
MO-UTR (both 8 ng) were injected and compared with WT embryos at 1, 2 and 3 dpf (Figure 2). 
In WT homogenates of 1dpf two Fxr1p isoforms can be detected of 73 and 75 kDa from which 
the 73 kDa form is the most prominent (Figure 2A).  In contrast, WT homogenates of 2 and 3 
dpf showed a more equal expression level between the two isoforms. Homogenates from MO-
injected embryos showed at all three time points a clear reduction in Fxr1p expression levels. To 
ensure equal gel loading an anti-actin staining was performed on the same blot (Figure 2B). 
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Figure	1. Fxr1 morphants display a striated muscle phenotype and severe cardiac malformations. Embryos were 
injected with 4 ng (B and G) and 8 ng MO-ATG (C, E and H). The fxr1 morphants at 1 dpf (B and C) show a curled and/
or reduced tail compared to the WT embryos (A). The reduction of the tail is more severe in the embryos injected 
with 8 ng of fxr1 MO-ATG (B) than 4 ng (C). Details of the tail (D and E) of the fxr1 morphants (E) show U-shaped 
somites instead of V-shaped somites in WT embryos at 1dpf (D). At 3 dpf, the muscle phenotype in fxr1 morphants is 
more pronounced and, in addition, a heart defect can be observed (G and H), whereas WT embryos show a normal 
heart development (F). Embryos injected with 4 ng fxr1 MO-ATG display an unlooped heart with a distinct ventricle 
and atrium at 3 dpf (G), while embryos injected with 8 ng MO-ATG lack the complete tail and displays a linear string-
like heart with severe pericardial oedema (H). Similar results were obtained with the second MO (MO-UTR) that 
was designed against the UTR of fxr1.
75- A
B
kDa
WT MO
1d
WT MO
2d
WT MO
3dFigure	 2. Western blot analysis of 
homogenates from wildtype embryos (WT) 
and MO-ATG (8 ng) injected embryos (MO) 
at 1, 2 or 3 dpf using monospecific antibodies 
against zebrafish Fxr1p. A) In WT homogenates 
two isoforms of Fxr1p (73 and 75 kDa) are 
recognized at this gestational age. Notably, 
WT embryos show a prominent 73 kDa 
form of Fxr1p at 1 dpf, whereas the 75 kDa 
form is almost absent. At later stages (2 and 
3 days), the ratio between the two isoforms 
has changed. Homogenates from embryos 
injected with MO-ATG show a significant 
reduction in Fxr1p expression. B) Actin 
expression levels are used as a control for 
equal gel loading
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Overall pathology of the fxr1 morphant
The overall pathology, with special emphasis on muscle development and cardiac dysfunction, 
was examined by HE staining of both paraffin and GMA sections of MO-injected embryos (4 
ng) and compared with WT embryos at 2 dpf. The paraffin section of an fxr1 morphant clearly 
showed the disorganisation of striated muscle (Figure 3A and B). At the anterior part of the tail, 
some myosepts are still recognizable, however, more posterior of the tail no myosepts are visible 
and no striations can be seen (figure 3B). GMA sections were made to study the morphology of 
sarcomeres. The nuclei of the sarcomeres showed an oval shape in WT embryos (Figure 3C) and 
also at the proximal part of the tail of the fxr1 morphants (Figure 3D). However, the distal part 
of the tail of the fxr1 morphants showed round rather than oval shaped nuclei of the sarcomeres, 
which indicates a delay in muscle differentiation. The paraffin sections of WT heart showed 
a looped heart with a distinct ventricle and atrium (Figure 3E), and although the heart of fxr1 
morphants showed a distinct ventricle and atrium as well, no cardiac looping could be observed 
(Figure 3F). In addition, these histological sections showed the presence of a dilated atrium and 
a dilated ventricle with a very thin muscle wall.
Figure	 3.	 HE stained muscle and heart 
sections of WT embryos (C and E) and fxr1 
morphants (MO-ATG, 4 ng; A, B, D and F) 
at 3 dpf. Longitudinal paraffin section of an 
fxr1 morphant is showing the striated muscle 
phenotype (A).  Detail of the severely reduced 
tail in the fxr1 morphant (B). At the anterior 
part of the tail myosepts can be observed, 
however, more posterior of the tail muscle 
organization is completely lost. GMA section 
of skeletal muscle from a WT embryo (C) and 
an fxr1 morphant (D) illustrating the normal 
presence of oval nuclei in WT embryos at 
this stage (3 dpf), whereas embryos injected 
with MO-ATG show predominantly round 
nuclei instead of oval, suggesting a delay in 
development. In paraffin sections of WT 
embryos (E) at 3 dpf the looped heart can be 
recognized with the ventricle (v) and atrium 
(a).  fxr1 morphants at 3 dpf show a distinct 
ventricle (v) and atrium (a), but no cardiac 
looping.
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Structural proteins present but delocalised
To further characterize the muscle tissue of fxr1 morphants, paraffin sections of 3 dpf embryos 
(both WT and fxr1 morphants) were stained using specific antibodies against important structural 
striated muscle proteins, including actin, dystrophin and vinculin. In WT embryos, the three 
proteins showed a differential expression pattern. Actin is expressed at high levels within the 
muscle fibres (Figure 4A), whereas dystrophin expression is located in the V-shaped myosepts 
(Figure 4B) and vinculin showed expression in both the muscle fibres and in the myosepts 
(Figure 4C). In fxr1 morphants, all three proteins were expressed at similar levels compared 
with WT, but the distribution was dramatically altered (Figures 4D-E). The normal architecture 
of the muscle tissue at the distal part of the morphants was completely lacking and muscle fibres 
were in different orientations. Strikingly, higher concentrations of the MO injected, resulted in 
disruption of the muscle architecture at the most anterior parts of the tail. 
Figure	4. Immunocytochemical distribution of structural proteins in striated muscle tissue of WT embryos (A-C) 
and fxr1 morphants (D-F) using paraffin sections. Sections are stained for actin (A and D), dystrophin (B and E) and 
vinculin (C and F).
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MyoD and Cmlc expression 
To determine whether other genes known to be involved in myogenesis were altered whole mount 
in situ hybridisation was performed. Myogenesis initiates during early somitogenesis with the 
expression of the muscle specific marker MyoD. MyoD plays a crucial role in the expression of 
muscle structural proteins and the assembly of myofibres. MyoD expression was examined in 
fxr1 morphants between 10 and 16 hpf. Figure 5A illustrates MyoD expression in WT embryos 
of 14 hpf (10-11 somite stage). Two longitudinal stripes along the notochord with lateral bands 
are clearly visible. In contrast, fxr1 morphants of 14 hpf showed less prominent and shorter 
lateral bands compared to WT (Figure 5B).
The thin muscle wall of the heart of fxr1 morphants might be caused by altered expression of 
sarcomeric proteins. Disruption of the heart marker cardiac myosin light chain (Cmlc) causes 
disturbance of cardiac myofibrillar assembly and was used to study the expression pattern in our 
fxr1 morphants. In WT embryos (2 dpf), Cmlc stained both cardiac chambers, the ventricle and 
the atrium. Figure 5C shows a normal looping of the heart. In the fxr1 morphants (8 ng) the heart 
tube showed Cmlc expression, however, no distinct ventricle and atrium could be discriminated 
(Figure 5D).
Figure	5. Whole mount in situ hybridization for MyoD and Cmlc gene expression in WT embryos and fxr1 morphants 
(MO-ATG, 8 ng). Characteristic MyoD expression in a WT embryo at 14 hpf (A) and altered MyoD expression in an 
fxr1 morphant (MO-ATG; 8ng) at 14 hpf showing less prominent and shorter lateral bands. Cmlc gene expression in a 
WT embryo at 2dpf visualises both the atrium and ventricle and show at this stage in development that the heart has 
undergone looping (C). Cmlc gene expression in an fxr1 morphant visualises that looping did not occur and instead the 
heart remains as a linear tube (D).
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Discussion
The FXR gene family is a small family of genes, including FMR1, FXR1 and FXR2, of which 
FMR1 is involved in the fragile X syndrome. Although no disease has been identified thus 
far involving FXR1P, the function is thought in part to be similar to FMRP, due to its high 
homology of important functional domains and similar expression patterns in the brain. FXR1P 
is the only family member that shows high expression in striated muscle tissue. Generation of 
Fxr1 knockout mice that die shortly after birth pointed towards a striated muscle phenotype, 
suggesting FXR1P plays an important role in the development of striated muscle tissue. 
However, the early embryogenesis is difficult to study in mouse embryos due to their intrauterine 
development. In the current study, this problem was overcome by studying FXR1P in zebrafish 
embryos. Zebrafish have a relatively simple musculature. In zebrafish embryos skeletal muscle 
arises from the somites and the first muscle fibres are slow 17. Here we report fxr1 knockdown 
experiments using the antisense morpholino technology and further characterisation of the fxr1 
morphants.
The fxr1 morphants displayed a striated muscle phenotype and developed congenital heart 
malformations. The severity of this striated muscle phenotype of the fxr1 morphants was dosage-
dependent, the higher the concentration of fxr1 MO, the more severe the phenotype. The muscle 
development in the tail was disturbed resulting in a reduced curled tail to even a totally absent 
tail and poor motility. The remainder of the tail showed complete loss of the characteristic 
striated muscle architecture. The presence of U-shaped tail somites in fxr1 morphants suggests a 
defect in the formation of the horizontal myosept and is characteristic of defects in slow muscle 
development 17.
In situ hybridisation studies in WT zebrafish embryos have shown that fxr1 mRNA is expressed 
in adaxial cells 11. Most of the adaxial cells migrate laterally from the notochord region to 
the entire surface of the myotome 18. A few of the adaxial cells remain medially located and 
differentiate to slow myosin heavy chain (MyHC) expressing muscle cells. These presomitic 
adaxial cells initiate muscle differentiation by expressing the myogenic regulatory factor MyoD. 
The fxr1 morphants display an aberrant MyoD pattern with shorter and less prominent lateral 
bands. This suggests that the adaxial cells do not migrate properly from notochord region to the 
lateral surface of the myotome. Thus, the fxr1 morphants have a very early myogenesis defect, 
which results in a phenotype involving midline structures. This disorganisation of the skeletal 
muscle tissue was also demonstrated by the immunostaining of the structural striated muscle 
proteins actin, dystrophin and vinculin. These structural proteins appeared to be expressed 
in fxr1 morphants of 3 dpf, but not in the organized fashion seen in WT embryos. The lack of 
organisation of the striated muscle seen in fxr1 zebrafish morphants corresponds to the phenotype 
observed in Fxr1 knockout mice 6. The Fxr1 knockout mouse also displayed disruption of the 
cellular architecture of striated muscle, including the heart. Fxr1 knockout mice die shortly after 
birth, while a second mouse model with reduced levels of Fxr1p (Fxr1-neo) could overcome this 
lethality after birth. The zebrafish fxr1 morphants are lethal at 4-6 dpf depending on the dosage 
of fxr1 MOs injected. Thus, like in the Fxr1 mouse models, the phenotype of zebrafish fxr1 
morphants is correlated with the level of reduced Fxr1p expression. 
Next to the muscle phenotype, disturbed cardiac development could be observed in our fxr1 
morphants. The severity of the heart malformations was also dosage-dependent. Between 24-
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48 hpf, the heart failed to undergo cardiac looping when treated with low concentration of 
MOs (4 ng), although the two chambers were normally formed. Embryos treated with higher 
concentration of MOs (8 ng) showed only the presence of a single heart tube without recognizable 
chambers and with extensive pericardial oedema. As a consequence of these abnormalities the 
heart function was reduced illustrated by a reduced heartbeat of both chambers. The cause of 
the pericardial oedema is probably a secondary event caused by the hypoplastic ventricular 
wall combined with poor cardiac output. Interestingly, no heart phenotype was reported in 
Xenopus Fxr1 MO knockdown experiments 9. These experiments in Xenopus showed that Fxr1p 
has an early role during somitogenesis. In the Fxr1 MO injected frog embryos, segmentation 
is inhibited and myotome development is abnormal. The fact that the authors did not observe a 
heart phenotype could be due to the knockdown of Fxr1 in only one side of the frog. Although 
Fxr1 knockout mice showed a disrupted architecture of the heart striated muscle, cardiac looping 
occurred and overall pathology was less pronounced compared to zebrafish 6. 
The molecular mechanisms of heart tube formation and subsequent cardiac looping remains 
poorly understood. Cardiac development requires interaction of several transcription factors 
in a tightly regulated fashion, including GATA factors. Recently, Walton et al. reported that 
the repression motif of Fog1, a multi-type zinc finger protein, was required for cardiac looping 
in zebrafish 19. Thus, the normal cellular function of Fog1 in cardiac development in zebrafish 
can be thought in the regulation of transcription of specific genes involved in cardiac looping. 
Fxr1p, an RNA binding protein, is present in mRNP particles and might be involved in transport 
and/or regulation of specific transcripts in striated muscle tissue, analogous to FMRP function 
in neurons 6,20,21. Based on this study we hypothesize that Fxr1p transports and/or regulates 
translation of mRNAs encoding proteins involved in early muscle morphogenesis, including 
costameric proteins and proteins involved in heart morphogenesis. Misrouting or reduced 
translation of these target mRNAs results in delocalised or reduced protein expression and as 
a consequence congenital abnormalities in striated muscle morphogenesis develop. Indeed, 
in our fxr1 morphants we observed delocalised costameric proteins in skeletal muscle tissue. 
Other factors involved in looping are diverse as microtubules, asymmetrically located bundles 
of actin, pressure of the cardiac jelly, and changes in the shape of individual myocardiac cells. 
One of the mechanisms of looping is active myocardial cell shape change, possibly due to 
actin polymerisation 22. Interestingly, Fxr1p associates with CYFIP2 (for Cytoplasmic FMRP 
Interacting Proteins). This protein interacts with the small GTPase Rac1, which in turn plays 
a role in the dynamic reorganisation of the actin cytoskeleton 23,24. Future research should be 
focused on the identification of the target mRNAs of fxr1 in striated muscle tissue during 
embryonic development. The results of these studies will lead to increased knowledge about 
the molecular mechanisms underlying normal and genetic disease of skeletal muscle, including 
muscular dystrophies and congenital myopathies. 
In conclusion, fxr1 plays a role in the differentiation and/or migration of adaxial cells within 
the myotome and lack of Fxr1p results in U-shaped somites and a defect in the formation of 
the horizontal myosept in zebrafish. In addition, fxr1 is required for normal cardiac looping in 
zebrafish.
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Animal models are often used to study the cellular function of specific genes in vivo. To study 
the function of the FXR genes, knockout (KO) mice have been generated for all three genes. 
Fmr1 KO mice display the characteristic features as seen in fragile X patients, like learning 
deficits and macroorchidism 117. In addition, they showed reduced pruning and/or maturation of 
the spines, which occurs during embryonic and early postnatal development 104,119-121. Therefore, 
the fragile X syndrome can be characterised as a developmental disorder. Also Fxr2 KO 
mice showed a mild learning and behavioural phenotype, however, further characterisation is 
necessary 124. Fxr1 KO mice showed a striated muscle phenotype and died shortly after birth 109. 
This suggests that Fxr1p plays an essential role during normal embryonic development. Thus 
an animal model that would allow functional studies during embryonic development would 
be beneficial to study FXR gene function. A good vertebrate model to study (early) embryonic 
development is the zebrafish and this thesis describes functional studies of the FXR genes in 
zebrafish.  
Zebrafish as a model to study human disease
Zebrafish is a well-established animal model to study development due to its small size, fast 
ex-utero development and optical clarity (see chapter 1.1). The last decades, the zebrafish has 
become increasingly popular as a vertebrate model to study human disease, because technology 
to manipulate gene expression has been further developed for zebrafish as well. There are some 
disadvantages to the use of zebrafish as a model organism. The zebrafish is a vertebrate and 
evolutionary more distant from human, which makes it that some processes need to be studied 
in a mammalian model, like the mouse model. However, there is a strong similarity between the 
zebrafish and the human genome and many developmental processes are conserved. Although, 
reverse and forward genetics in zebrafish is developing very quickly, generating specific 
mutations is still rather difficult in zebrafish. In ENU-mutagenized zebrafish screens, many 
zebrafish mutants have been identified, but the transgenic techniques are not as established as 
in the mouse. However, it is very difficult to study the early embryonic development in mouse 
due to the development of the embryos in utero. Another advantage of zebrafish is the ability 
to absorb small molecules from the water. Until 12-14 dpf, their oxygen supply is by diffusion 
across the skin. These features make the zebrafish suitable for pharmacological use. They can 
live in these early days of their life in a 96-wells plate, which make high throughput drug screens 
possible. 
In the next paragraphs, I will discuss a number of examples that are relevant in the light of the 
research discussed in this thesis. To date, many zebrafish have been identified which display 
a phenotype that resembles a human disease. Zebrafish are attractive as model of myopathy 
because they have high skeletal muscle content and express orthologs of most human DGC 
proteins with similar membrane localisation 151,152. A nice example is the zebrafish mutant, called 
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sapje, which has a mutation in the ortholog of dystrophin, which causes Duchenne or Becker 
muscular dystrophies in human patients 50. The degeneration of normally differentiated skeletal 
muscle tissue in these patients is thought to be caused by disconnection of the cytoskeleton 
from the extracellular matrix by reduction. Dystrophin is part of the Dystrophin-Associated 
Protein Complex (DAPC), which transmits forces between the ends of the muscle fibres 153,154. 
This complex has been shown to be present in zebrafish 151. The sapje mutant zebrafish displays 
progressive degeneration of skeletal muscle with embryonic onset 50. Dystrophin has also 
been knocked down in zebrafish using antisense morpholino knockdown technology. These 
morphants showed a bent and curved phenotype and were less motile compared to wildtype 
fish. Experiments on the sapje mutant showed that the degeneration was caused by separation 
of somitic muscle fibres from their attachments point on the myosept 151. Myosepts are tendon-
like sheets of extracellular matrix that separate segmented blocks of non-overlapping fibres. 
In mammalian muscles, these structures are called myotendinous junction. The requirement 
of dystrophin at sites of muscle attachment in the zebrafish suggested that the myotendinous 
junction of the human muscle might be an important site for the pathogenesis of DMD. The 
phenotype observed in zebrafish is more severe than seen in the mouse dystrophin mutant mdx. 
This is due to the level of utrophin, which protects the muscle of the mouse and is not present 
in human and zebrafish 155. Despite the use of other animal models for DMD, the zebrafish is a 
valuable complementary animal model to the study of muscular dystrophies.  
The zebrafish has a relatively simple neuro-muscular organisation and its nervous system is well 
characterised. Therefore, the zebrafish was used as a model to study spinal muscular atrophy 
(SMA), which is a neuromuscular disease with infant mortality. It is caused by low level of 
survival motor neuron (SMN) protein resulting in loss of α motor neurons in the spinal cord 
156. Morpholino knockdown studies suggest that reduced levels of SMN cause a defect in the 
developing motor neuron. Characterisation of the SMN morphants showed an axon-specific 
path finding and outgrowth defect leading to loss of motor neurons 157.
Neurodegenerative diseases, such as inherited forms of Parkinson’s disease (PD), have been 
associated with mutations in specific genes. Genetic analyses of familial PD have identified 
several genes that lead to PD when mutated. These genes include α-synuclein, parkin, DJ-1, PINK1 
and LRRK2 158. The advantages of zebrafish as a model organism to study neurodegeneration 
are the ability to study the in vivo function using fluorescent markers and the availability of 
techniques that allow efficient generation of transgenic animals. Furthermore, as mentioned 
above, they can absorb small molecules from the water, which makes them suitable for high 
throughput drug screens to test potential drugs for PD patients. Moreover, the dopaminergic 
system is complex and well developed in zebrafish 159 and a region anatomically similar to the 
striatum was identified in the forebrain 160. Parkinson’s disease (PD) is characterised by the 
progressive loss of dopaminergic neurons in the substantia nigra and movement defects. Protein 
deposits characterize Parkinson brains and zebrafish can be used as a model to understand 
mechanisms of neurotoxicity of these deposits. Next to the advantage of genetic screens, the 
zebrafish can be given with PD-inducing neurotoxins (MPTP, rotenone, and paraquat), which 
eventually leads to loss of DA neurons 161. Recently, it was shown that DJ-1 is evolutionarily 
conserved and expressed in dopaminergic neurons of zebrafish 162.
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Thus, the zebrafish is an ideal vertebrate animal model to study (disease) gene function during 
early embryonic development and, in addition, very suitable to be used as a complementary 
system to the mouse.  
Zebrafish versus Xenopus
Although Xenopus is also widely used as a model to study embryonic development, we chose 
to use the zebrafish to study the function of FXR1P. A major advantage of using Xenopus as a 
model is the phenomena of the development each cell of a two-cell stage into either the left or 
the right side of the embryos. When only one cell is injected, the other halve of the embryo can 
be used as an internal control. However, the Xenopus laevis is a tetraploid and relatively slow 
growing compared to Xenopus tropicalis, which is diploid. For Xenopus tropicalis, Fmr1 and 
Fxr1 genes could be identified, but Fxr2 was not 112. Both the frog and zebrafish are established 
animal models for embryonic development. In addition, the zebrafish has been used as a model 
for myogenesis and myopathies 67,163. Therefore, we used the zebrafish as a model to study the 
cellular function of FXR1P.
Evolutionary conservation of Fxr1p
To be able to use the zebrafish as an animal model to study the FXR genes, these genes have 
to be present in the zebrafish and expressed in the same tissues as in human, preferably. In the 
zebrafish genome, all three fxr genes could be identified and appear to be conserved during 
evolution. The domains important for the function of the fxr genes are highly homologous to 
the human genes, which suggests that the function of the fxr proteins in zebrafish is similar to 
the function in human (Chapter 5, 164; 165). The expression pattern of both Fmrp and Fxr1p in 
zebrafish has been thoroughly studied and appeared to have similar distributions as in human 
and mouse. Fmrp is predominantly expressed in the neurons of the brain. In skeletal muscle 
no Fmrp expression could be detected, similar to the human situation (Chapter 4, 165). Fxr1p is 
moderately expressed in the neurons of the brain, immature spermatogenic cells of the testis 
and highly expressed at the myosept and costamere-like structure of skeletal muscle tissue 
(Chapter 5, 164). With the fmr1 and fxr1 orthologs being evolutionary conserved and showing 
similar expression patterns, zebrafish can be used as a model to study the function of Fmrp and 
Fxr1p during embryonic development. 
Fxr1 morphants
The fxr1 MO injected zebrafish embryos or fxr1 morphants showed disorganisation of the 
striated muscle and a severe heart phenotype, which includes the absence of looping and the 
presence of pericardial oedema. The phenotype showed a dosage-dependent effect and fxr1 
morphants died at 4-6 dpf depending on the concentration of injected fxr1 MO. Characterisation 
of the fxr1 morphants showed an aberrant migration of adaxial cells, indicating a defect in early 
steps of muscle development. Although the structural organisation is lost, structural proteins, 
like dystrophin, vinculin and actin, were present but delocalised. The phenotype of the fxr1 
morphants corresponds to the main characteristics observed in Fxr1 KO mice, which lack the 
structural organisation of both skeletal muscle and the heart 109. Experiments with Fxr1 MO 
injection in the Xenopus laevis showed similar muscle specific defects 150. Striking is the heart 
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phenotype that is observed in the fxr1 morphants. Dependent on the dosage, it varied from a 
linear heart for low concentrations of fxr1 MO to a string-like heart with no distinct ventricle 
and atrium for higher concentrations of fxr1 MO. In the Fxr1 KO mice, the heart lacks the 
organisation, but is normally looped. In the Fxr1 MO injected frog, no heart phenotype has been 
described. Apparently, Fxr1p plays a role in the differentiation and/or migration of adaxial cells 
within the myotome and lack of Fxr1p results in U-shaped somites and a defect in the formation 
of the horizontal myosept in zebrafish. In addition, Fxr1p is required for normal cardiac looping 
in zebrafish.
Considering the advantages of zebrafish to study early embryonic development, the fxr1 
morphant is a good vertebrate model to further study the development of striated muscle and 
the function of Fxr1p in this process. 
Fxr1p function
From mouse studies we have learned that Fxr1p is highly expressed in a punctuated pattern in 
skeletal muscle. This pattern is thought to be reflecting the localisation of Fxr1p in costameric 
structures 107,109. Costameres are protein complexes consisting of cytoskeleton, transmembrane 
glycoproteins, and extracellular matrix. They connect the extracellular matrix to the Z-disks 
of the muscle and thereby transfer tension from contractile elements to connective tissue 153. In 
zebrafish, a similar punctuated expression pattern was observed in skeletal muscle, especially at 
the myosept (Chapter 5, 164). Colocalisation studies in zebrafish muscle demonstrated that Fxr1p 
expression partially overlaps with dystrophin and vinculin expression. Both dystrophin and 
vinculin are components of costameric structures 67. Thus, considering its functional domains 
and its expression pattern in muscle, Fxr1p is hypothesized to play a role in transport and/or 
translation of specific mRNAs at the costamere. In line with this hypothesis, large numbers of 
actively transcribing polyribosomes have been identified at the myosept and also at costameric 
sites 166,167. Translational control at costameric sites has already been shown to occur for the 
protein Raver1 168. Raver1 is thought to coordinate RNA processing and targeting of vinculin 
and α-actinin. 
Due to the premature death of the Fxr1 KO mice and fxr1 zebrafish morphants, Fxr1p is thought 
to have an essential function during early muscle development. Muscle development involves 
many changes in cell morphology and cytoskeletal arrangements. During myofibrillogenesis, 
assembly of structural proteins is necessary to enable the development of highly organized striated 
muscle. Soon after myofibril formation, they become highly structured and in distinct stages will 
develop into mature striated muscle (reviewed in 68). Little is known about how muscles achieve 
their highly structured organisation. Recently, this process of myofibrillogenesis was shown to 
be tightly coupled to costamere formation. Although the structural organisation of the muscle is 
lost, all structural proteins are present. Within this, the role of Fxr1p is translational control and 
transport mRNAs encoding costameric proteins during muscle development. Misrouting and/or 
perturbed translation of target mRNAs might result in muscle lacking structural organisation.
The heart phenotype observed in the fxr1 morphants shines a new light on the function of Fxr1p. 
Characterisation of the cellular basis for cardiac looping has proven very difficult. Factors 
involved in cardiac looping are diverse as microtubules, asymmetrically located bundles of 
actin, pressure of the cardiac jelly, and changes in the shape of individual myocardiac cells. 
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One of the mechanisms of looping is active myocardial cell shape change, possibly due to 
actin polymerisation 169. Interestingly, Fxr1p associates with CYFIP2 (for Cytoplasmic FMRP 
Interacting Proteins). This protein interacts with the small GTPase Rac1, which in turn plays a 
role in the dynamic reorganisation of the actin cytoskeleton 170,171.
Future experiments
Another way to study specific gene function is to overexpress Fxr1p in zebrafish. Transgenic fish 
with an inserted fusion protein, like GFP-Fxr1p, under the control of a specific promoter enable 
to monitor gene expression and other cellular processes in vivo. 
FMRP is involved in pruning and/or maturation of the spines, a process that occurs during 
embryonic and early postnatal development 104,119-121. It might therefore be interesting to use the 
zebrafish as a model to study the function of FMRP as well. Extrapolation of the data in mouse 
studies, suggests an Fmr1 knockout/knockdown zebrafish to have altered spine morphology and 
affected synapse formation. When fmr1 MOs are used to knockdown fmr1, changing the amount 
of MO injected could vary the level of Fmrp. In addition, it would be interesting to see if there 
is a phenotype and whether the phenotype is reversible when the effect of the MOs stops after 
4 days and normal Fmrp production starts. Recently, an fmr1 KO fish was generated using the 
TILLING technique (personal communication R. Ketting/E. Cuppen, Hubrecht Laboratory). 
Like the Fmr1 KO mouse model, this fmr1 KO fish could be tested for certain behavioural 
abnormalities. Ethovision from Noldus is a computerized video tracking system that enables 
to record movement of animals including swimming patterns of small sized fish. Learning and 
memory of fish can be studied using a T-maze test combined with the Ethovision system. This 
behavioural test can also be used to study Fxr2p function in zebrafish using fxr2 morphants. 
An advantage of MOs is the possibility to inject more than one MO simultaneously. For instance, 
by injecting MOs against the FXR proteins simultaneously, all three proteins can be knocked 
down in many combinations. In this way the level of redundancy among the FXR proteins can 
be studied.  
In conclusion, the zebrafish is a suitable vertebrate model system to study the in vivo FXR 
protein function and especially attractive to study gene function during embryonic and neonatal 
development. Thereby, the zebrafish is a good complementary animal model to the mouse. 
Elucidating the cellular function of Fxr1p helps to understand the functions of Fmrp and/or 
Fxr2p as well. Although, no human disease has been linked to Fxr1p up till now, zebrafish can 
be used to investigate early muscle development.
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Summary
The FMR1 protein, FMRP, has been extensively studied due to its involvement in the fragile 
X syndrome, which is mainly characterised by mental retardation, macroorchidism and facial 
dysmorphologies. The FMR1 gene is transcriptionally inactivated by the methylation of its 
promoter region due to the expansion of a CGG repeat. Thus the fragile X syndrome is caused 
by the absence of the protein FMRP. FMRP is part of a small RNA binding protein family, 
which also include FXR1P and FXR2P. Due to the high homology of important functional 
domains and similar expression patterns in the brain, FXR1P and FXR2P are thought to have a 
similar function to FMRP. All three proteins are ubiquitously expressed with high expression in 
brain and testis. In addition, FXR1P is highly expressed in striated muscle tissue. The cellular 
function of the FXR proteins has been studied by the generation of knockout mouse models 
for all three genes. The Fmr1 KO mice display similar features as fragile X patients, including 
learning and memory abnormalities and macroorchidism. Further characterisation of the Fmr1 
KO mice showed a reduced pruning and/or maturation of spines, which normally occurs during 
late embryonic and postnatal development. Fxr1 KO mice showed a severe striated muscle 
phenotype and died shortly after birth. This early lethality indicates that cellular Fxr1p function 
is critical during embryonic development. Fxr2 KO mice showed a discrete behavioural 
phenotype, but needs further characterisation to determine whether Fxr2p has a role during 
embryonic development. Processes during embryonic development are difficult to study in the 
mouse model due to in utero development of the embryos. For this reason, we have chosen 
the zebrafish (Danio rerio) as a model to study the FXR protein function especially during 
embryonic development.
The zebrafish is a well-established simple vertebrate animal model. Their ability to be kept in 
large numbers and the ease of breeding make them easy to maintain. Due to its transparent 
embryos that develop externally the zebrafish represents an ideal model to study processes 
during embryonic development. In addition, the embryos develop quickly from a single cell to 
something that is recognizable as a fish after 24 hours of development. The favourite method 
to study gene function in zebrafish is the generation of a morpholino-mediated knockdown 
zebrafish. This morpholino technology is based on the injection of synthetic antisense 
oligonucleotides into a 1-8 cell stage embryo, which subsequently binds to the mRNA molecule 
and thereby preventing translation. The introduction of this thesis (chapter 1) describes the use 
of zebrafish as a vertebrate animal model with special emphasis to human disease (part 1) and 
introduces the FXR protein family with its three individual members (part 2). The aim of this 
thesis is to gain insight in the function of the FXR proteins, and their role during embryonic 
development particularly using the zebrafish as a model system.
Another simple animal model organism suitable to study embryonic development is the frog 
Xenopus tropicalis. Characterisation of the FXR proteins in the Xenopus tropicalis led only 
to the identification of Fmrp and Fxr1p and not Fxr2p. In adult frogs both proteins are highly 
expressed in most neurons of the central nervous system and in all spermatogenic cells in the 
testis. In addition, Fxr1p is also highly expressed in striated muscle tissue (chapter 2). 
A first step in studying the FXR proteins in zebrafish is the characterisation of these proteins in 
this model. All FXR proteins are evolutionary conserved in zebrafish. The expression pattern 
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of both Fmrp and Fxr1p was studied using specific antibodies against the zebrafish proteins. 
Fmrp expression is high in specific neurons of the brain and very weak in the testis. In brain 
tissue, only two prominent isoforms of Fmrp could be detected, compared to four prominent 
isoforms in human and mouse brain tissue. Fxr1p is expressed in neurons throughout the brain, 
in immature cells of the testis and in skeletal muscle. The high expression of Fxr1p in skeletal 
muscle is localised at the myosept and in costamere-like granules. For Fxr1p in zebrafish, 
different tissue-specific isoforms were characterised compared to human and mouse. Due to 
similar expression patterns and the high homology of the functional domains of both Fmrp and 
Fxr1p make the zebrafish a suitable animal model to study the cellular function of FMRP and 
FXR1P during embryonic development (chapter 3 and 4).
The function of Fxr1p was studied using the antisense morpholino knockdown technique. The 
fxr1 knockdown zebrafish display a striated muscle phenotype and severe heart malformations. 
Initial characterisation of the fxr1 morphants showed an abnormal somite formation, which 
resulted in delocalisation of muscle proteins, including dystrophin, vinculin and actin. In 
contrast to other Fxr1p animal models, a failure in looping of the heart was also observed. 
FXR1P is thought to be involved in transport and/or regulation of specific transcripts in striated 
muscle, analogous to FMRP function in neurons (chapter 5).
In conclusion, the zebrafish appeared to be a suitable animal model to study the cellular function 
of both FMRP and FXR1P during embryonic development. The use of zebrafish as a model for 
human disease, the fxr1 morphants and the possible cellular function of FXR1P are discussed 
in chapter 6.
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Samenvatting
Het FMR1 eiwit, FMRP, is uitgebreid bestudeerd vanwege zijn betrokkenheid bij het fragiele 
X syndroom, dat voornamelijk gekenmerkt wordt door mentale retardatie, macroorchidisme 
en dysmorfologieën in het gezicht. Een verlenging van een CGG repeat in het FMR1 gen zorgt 
voor de methylatie van het promotorgebied en voorkomt daarmee transcriptie. De afwezigheid 
van FMRP veroorzaakt het fragiele X syndroom. FMRP is onderdeel van een kleine familie van 
RNA bindende eiwitten, waartoe ook FXR1P en FXR2P behoren. Vanwege de hoge homologie 
in de belangrijke functionele domeinen en een vergelijkbaar expressiepatroon van FXR1P 
en FXR2P in het brein, wordt aangenomen dat zij dezelfde functie hebben als FMRP. De 3 
eiwitten komen hoog tot expressie in brein en testis. Daarnaast komt FXR1P hoog tot expressie 
in dwarsgestreept spierweefsel. De cellulaire functie van de FXR eiwitten is bestudeerd met 
behulp van knockout muis modellen voor de 3 genen. De Fmr1 KO muizen hebben kenmerken 
vergelijkbaar met een fragiele X patiënt, zoals leer- en geheugenproblemen en macroorchidism. 
Verdere karakterisatie van deze muizen laat zien dat zij verminderde volgroeiing van de 
zenuwen hebben, dat normaal tijdens de laat embryonale en vroege postnatale ontwikkeling 
gebeurt. Fxr1 KO muizen hebben een ernstig spierfenotype, waarbij het dwarsgestreepte 
spierweefsel aangedaan is. De pups overlijden vlak na de geboorte, dat aangeeft dat Fxr1p een 
belangrijke rol speelt bij de embryonale ontwikkeling. De Fxr2 KO muizen hebben een discreet 
gedragsfenotype, dat verder gekarakteriseerd moet worden om te bepalen of Fxr2p een rol speelt 
in de embryonale ontwikkeling. Doordat de embryonale ontwikkeling van de muis plaatsvindt 
in de baarmoeder is het moeilijk deze te bestuderen in muis modellen. Daarom hebben wij 
gekozen voor de zebravis als diermodel voor de bestudering van de functie van de FXR eiwitten, 
met name tijdens de embryonale ontwikkeling.
De zebravis is een simpel vertebraat diermodel, dat zich bewezen heeft voor onderzoek. De 
mogelijkheid om ze in grote aantallen te huisvesten en het gemak van voortplanten, maakt ze 
eenvoudig te houden. Doordat de embryo’s transparant zijn en buiten de moeder groeien is de 
zebravis een ideaal model om embryonale ontwikkeling te bestuderen. Daarnaast ontwikkelt 
een embryo zich binnen 24 uur van eencellige tot een complete vis. De favoriete methode om 
genfunctie te bestuderen in zebravis is het maken van een morpholino-geinduceerde knockdown 
zebravis. De morpholino technologie is gebaseerd op het injecteren van synthetische antisense 
oligonucleotieden in een 1 tot 8-cellig embryo. De morpholino bindt vervolgens aan het mRNA 
molecuul en voorkomt hiermee translatie. De introductie van dit proefschrift (hoofdstuk1) 
beschrijft het gebruik van de zebravis als vertebraat diermodel met name voor humane 
ziektebeelden (deel 1) en introduceert de drie leden van de FXR eiwit familie (deel 2). Het doel 
van dit proefschrift is om inzicht te krijgen in de functie van de FXR eiwitten met name tijdens 
de embryonale ontwikkeling door het gebruik van de zebravis als diermodel.
Een ander simpel diermodel dat geschikt is voor het bestuderen van de embryonale ontwikkeling 
is de kikker Xenopus tropicalis. Karakterisatie van de FXR eiwitten in de kikker heeft geleid 
tot de identificatie van Fmrp en Fxr1p, maar niet van Fxr2p. In volwassen kikkers komen beide 
eiwitten hoog tot expressie in de meeste neuronen van het centrale zenuwstelsel en in alle 
spermacellen van de testis. Daarnaast komt Fxr1p ook hoog tot expressie in dwarsgestreept 
spierweefsel (hoofdstuk 2).
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De eerste stap in het bestuderen van de FXR eiwitten in de zebravis is de karakterisatie van deze 
eiwitten in dit model. Alle FXR eiwitten zijn tijdens de evolutie geconserveerd in de zebravis. 
Het expressiepatroon van zowel Fmrp en Fxr1p is bestudeerd met behulp van antilichamen 
specifiek tegen de zebravis eiwitten. De Fmrp expressie is hoog in specifieke neuronen van het 
brein en is zwak in de testis. In het brein zijn slechts twee isovormen van Fmrp gedetecteerd in 
vergelijking met de vier isovormen die voorkomen in het brein van mens en muis. Fxr1p komt tot 
expressie in de neuronen van het brein, onvolwassen cellen van de testis en skeletspier. De hoge 
expressie van Fxr1p in skeletspier wordt voornamelijk gezien in de myosepten en in costameer-
achtige granulen. In vergelijking met mens en muis heeft Fxr1p in zebravis andere weefsel-
specifieke isovormen. Vanwege de gelijkende expressiepatronen en de hoge homologie van de 
functionele domeinen van zowel Fmrp en Fxr1p is de zebravis een geschikt diermodel voor het 
bestuderen van de cellulaire functie van FMRP en FXR1P tijdens de embryonale ontwikkeling 
(hoofdstuk 3 en 4).
De functie van Fxr1p is bestudeerd met behulp van antisense morpholino knockdown techniek. 
De fxr1 knockdown vissen hebben een fenotype van het dwarsgestreepte spierweefsel en 
het hart. Een eerste karakterisatie van deze fxr1 knockdown vissen laat een abnormale 
somietvorming zien, dat resulteert in delocalisatie van spiereiwitten als dystrofine, vinculine en 
actine. In tegenstelling tot andere Fxr1p diermodellen laten de fxr1 knockdown vissen ook een 
misvorming aan het hart zien, waarbij het hart niet gevouwen is. FXR1P is wellicht betrokken 
bij het transport en regulatie van specifieke transcripten in dwarsgestreept spierweefsel, analoog 
aan de functie van FMRP in neuronen (hoofdstuk 5).
De zebravis bleek geschikt als diermodel voor de bestudering van de cellulaire functie van 
zowel FMRP als FXR1P tijdens de embryonale ontwikkeling. Het gebruik van de zebravis als 
diermodel voor humane ziektebeelden, de fxr1 knockdown vissen en de mogelijke functie van 
FXR1P worden bediscussieerd in hoofdstuk 6.
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